<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Atrial fibrillation,Articles with unsourced statements since September 2007,Articles with unsourced statements since August 2007,Heart diseases,Congenital malformations and deformations of circulatory system,Heart and thymus neoplasia,AV nodal reentrant tachycardia,Ablation,Accelerated idioventricular rhythm,Acute coronary syndrome,Acute myocardial infarction" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Atrial_fibrillation&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Atrial_fibrillation&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Atrial fibrillation - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Atrial_fibrillation";
		var wgTitle = "Atrial fibrillation";
		var wgAction = "view";
		var wgArticleId = "20869694";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281364864;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Atrial_fibrillation skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Atrial fibrillation</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Atrial fibrillation</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:SinusRhythmLabels.svg" class="image" title="SinusRhythmLabels.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/9e/SinusRhythmLabels.svg/190px-SinusRhythmLabels.svg.png" width="190" height="187" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>The P waves, which represent depolarization of the atria, are absent during atrial fibrillation.</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_I" title="ICD-10 Chapter I" class="mw-redirect">I</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gi30.htm+i48" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gi30.htm+i48" rel="nofollow">48.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=427.31" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=427.31" rel="nofollow">427.31</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb1065.htm" class="external text" title="http://www.diseasesdatabase.com/ddb1065.htm" rel="nofollow">1065</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000184.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000184.htm" rel="nofollow">000184</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic184.htm" class="external text" title="http://www.emedicine.com/med/topic184.htm" rel="nofollow">med/184</a>&#160; <a href="http://www.emedicine.com/emerg/topic46.htm#" class="external text" title="http://www.emedicine.com/emerg/topic46.htm#" rel="nofollow">emerg/46</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D001281" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D001281" rel="nofollow">D001281</a></td>
</tr>
</table>
<p><b>Atrial fibrillation</b> (<b>AF</b> or <b>afib</b>) is the most common <a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">cardiac arrhythmia</a> (abnormal heart rhythm) and involves the two upper chambers (<a href="/wiki/Atrium_(anatomy)" title="Atrium (anatomy)" class="mw-redirect">atria</a>) of the <a href="/wiki/Heart" title="Heart">heart</a>. Its name comes from the fibrillating (i.e. quivering) of the heart muscles of the atria, instead of a coordinated contraction. It can often be identified by taking a <a href="/wiki/Pulse" title="Pulse">pulse</a> and observing that the heartbeats don't occur at regular intervals. However, a conclusive indication of AF is the absence of P&#160;waves on an <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">electrocardiogram</a> (ECG), which are normally present when there is a coordinated atrial contraction at the beginning of each heart beat.<sup id="cite_ref-AHAafibForProfessionals_0-0" class="reference"><a href="#cite_note-AHAafibForProfessionals-0" title=""><span>[</span>1<span>]</span></a></sup> Risk increases with age, with 8% of people over 80 having AF.</p>
<p>In AF, the normal electrical impulses that are generated by the <a href="/wiki/Sinoatrial_node" title="Sinoatrial node">sinoatrial node</a> are overwhelmed by disorganized electrical impulses that originate in the atria and pulmonary veins, leading to conduction of irregular impulses to the <a href="/wiki/Ventricle_(heart)" title="Ventricle (heart)">ventricles</a> that generate the heartbeat. The result is an irregular heartbeat which may occur in episodes lasting from minutes to weeks, or it could occur all the time for years. The natural tendency of AF is to become a chronic condition. Chronic AF leads to a small increase in the risk of death.<sup id="cite_ref-pmid9737513_1-0" class="reference"><a href="#cite_note-pmid9737513-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>Atrial fibrillation is often <a href="/wiki/Asymptomatic" title="Asymptomatic" class="mw-redirect">asymptomatic</a>, and is not in itself generally life-threatening, but may result in <a href="/wiki/Palpitations" title="Palpitations" class="mw-redirect">palpitations</a>, <a href="/wiki/Fainting" title="Fainting" class="mw-redirect">fainting</a>, <a href="/wiki/Angina_pectoris" title="Angina pectoris">chest pain</a>, or <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a>. People with AF usually have a significantly increased risk of <a href="/wiki/Stroke" title="Stroke">stroke</a> (up to 7 times that of the general population). Stroke risk increases during AF because blood may pool and form clots in the poorly contracting atria and especially in the <a href="/wiki/Left_atrial_appendage" title="Left atrial appendage">left atrial appendage</a> (LAA). The level of increased risk of stroke depends on the number of additional risk factors. If a person with AF has none, the risk of stroke is similar to that of the general population.<sup id="cite_ref-pmid17548732_3-0" class="reference"><a href="#cite_note-pmid17548732-3" title=""><span>[</span>4<span>]</span></a></sup> However, many people with AF do have additional risk factors and AF is a leading cause of stroke.<sup id="cite_ref-Wolf1978_4-0" class="reference"><a href="#cite_note-Wolf1978-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>Atrial fibrillation may be treated with medications which either slow the heart rate or revert the heart rhythm back to normal. Synchronized electrical <a href="/wiki/Cardioversion" title="Cardioversion">cardioversion</a> may also be used to convert AF to a normal heart rhythm. Surgical and catheter-based therapies may also be used to prevent recurrence of AF in certain individuals. People with AF are often given <a href="/wiki/Anticoagulants" title="Anticoagulants" class="mw-redirect">anticoagulants</a> such as <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> to protect them from stroke.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Screening"><span class="tocnumber">3.1</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-2"><a href="#Routine_primary_care_visit"><span class="tocnumber">3.2</span> <span class="toctext">Routine primary care visit</span></a></li>
<li class="toclevel-2"><a href="#Minimal_evaluation"><span class="tocnumber">3.3</span> <span class="toctext">Minimal evaluation</span></a>
<ul>
<li class="toclevel-3"><a href="#History_and_physical_examination"><span class="tocnumber">3.3.1</span> <span class="toctext">History and physical examination</span></a></li>
<li class="toclevel-3"><a href="#Routine_bloodwork"><span class="tocnumber">3.3.2</span> <span class="toctext">Routine bloodwork</span></a></li>
<li class="toclevel-3"><a href="#Electrocardiogram"><span class="tocnumber">3.3.3</span> <span class="toctext">Electrocardiogram</span></a></li>
<li class="toclevel-3"><a href="#Echocardiography"><span class="tocnumber">3.3.4</span> <span class="toctext">Echocardiography</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Extended_evaluation"><span class="tocnumber">3.4</span> <span class="toctext">Extended evaluation</span></a>
<ul>
<li class="toclevel-3"><a href="#Chest_X-ray"><span class="tocnumber">3.4.1</span> <span class="toctext">Chest X-ray</span></a></li>
<li class="toclevel-3"><a href="#Transesophageal_echocardiogram"><span class="tocnumber">3.4.2</span> <span class="toctext">Transesophageal echocardiogram</span></a></li>
<li class="toclevel-3"><a href="#Ambulatory_holter_monitoring"><span class="tocnumber">3.4.3</span> <span class="toctext">Ambulatory holter monitoring</span></a></li>
<li class="toclevel-3"><a href="#Exercise_stress_testing"><span class="tocnumber">3.4.4</span> <span class="toctext">Exercise stress testing</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Etiology"><span class="tocnumber">4</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">5</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Morphology"><span class="tocnumber">5.1</span> <span class="toctext">Morphology</span></a></li>
<li class="toclevel-2"><a href="#Electrophysiology"><span class="tocnumber">5.2</span> <span class="toctext">Electrophysiology</span></a></li>
<li class="toclevel-2"><a href="#Thromboembolism"><span class="tocnumber">5.3</span> <span class="toctext">Thromboembolism</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Anticoagulation"><span class="tocnumber">6.1</span> <span class="toctext">Anticoagulation</span></a>
<ul>
<li class="toclevel-3"><a href="#Acute_anticoagulation"><span class="tocnumber">6.1.1</span> <span class="toctext">Acute anticoagulation</span></a></li>
<li class="toclevel-3"><a href="#Chronic_anticoagulation"><span class="tocnumber">6.1.2</span> <span class="toctext">Chronic anticoagulation</span></a></li>
<li class="toclevel-3"><a href="#Elderly_patients"><span class="tocnumber">6.1.3</span> <span class="toctext">Elderly patients</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Cardioversion"><span class="tocnumber">6.2</span> <span class="toctext">Cardioversion</span></a></li>
<li class="toclevel-2"><a href="#Rate_control_versus_rhythm_control_using_drugs"><span class="tocnumber">6.3</span> <span class="toctext">Rate control versus rhythm control using drugs</span></a></li>
<li class="toclevel-2"><a href="#Rate_control"><span class="tocnumber">6.4</span> <span class="toctext">Rate control</span></a></li>
<li class="toclevel-2"><a href="#Maintenance_of_sinus_rhythm"><span class="tocnumber">6.5</span> <span class="toctext">Maintenance of sinus rhythm</span></a>
<ul>
<li class="toclevel-3"><a href="#Antiarrhythmic_agents"><span class="tocnumber">6.5.1</span> <span class="toctext">Antiarrhythmic agents</span></a></li>
<li class="toclevel-3"><a href="#Catheter_ablation"><span class="tocnumber">6.5.2</span> <span class="toctext">Catheter ablation</span></a></li>
<li class="toclevel-3"><a href="#Cox_maze"><span class="tocnumber">6.5.3</span> <span class="toctext">Cox maze</span></a></li>
<li class="toclevel-3"><a href="#Minimally_invasive_maze_procedures"><span class="tocnumber">6.5.4</span> <span class="toctext">Minimally invasive maze procedures</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">9</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Classification" id="Classification"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a>]</span> <span class="mw-headline">Classification</span></h2>
<p>The <a href="/wiki/American_College_of_Cardiology" title="American College of Cardiology">American College of Cardiology</a> (ACC), <a href="/wiki/American_Heart_Association" title="American Heart Association">American Heart Association</a> (AHA), and the <a href="/wiki/European_Society_of_Cardiology" title="European Society of Cardiology">European Society of Cardiology</a> (ESC) recommend in their guidelines the following classification system based on simplicity and clinical relevance.<sup id="cite_ref-pmid16908781_5-0" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<table class="wikitable" style="margin: 1em auto 1em auto">
<tr>
<th width="100"><b>AF Category</b></th>
<th width="350"><b>Defining Characteristics</b></th>
</tr>
<tr>
<td>&#160; First detected</td>
<td>&#160; only one diagnosed episode</td>
</tr>
<tr>
<td>&#160; Paroxysmal</td>
<td>&#160; recurrent episodes that self-terminate in less than 7 days</td>
</tr>
<tr>
<td>&#160; Persistent</td>
<td>&#160; recurrent episodes that last more than 7 days</td>
</tr>
<tr>
<td>&#160; Permanent</td>
<td>&#160; an ongoing long-term episode</td>
</tr>
</table>
<p>All atrial fibrillation patients are initially in the category called <i>first detected AF</i>. These patients may or may not have had previous undetected episodes. If a first detected episode self-terminates in less than 7&#160;days and then another episode begins later on, the case has moved into the category of <i>paroxysmal AF</i>. Although patients in this category have episodes lasting up to 7&#160;days, in most cases of paroxysmal AF the episodes will self-terminate in less than 24&#160;hours. If instead the episode lasts for more than 7&#160;days, it is unlikely to self-terminate<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> and it is called <i>persistent AF</i>. In this case, the episode may be terminated by <a href="/wiki/Cardioversion" title="Cardioversion">cardioversion</a>. If cardioversion is unsuccessful or it is not attempted, and the episode is ongoing for a long time (e.g. a year or more), the patient's AF is called <i>permanent</i>.</p>
<p>Episodes that last less than 30&#160;seconds are not considered in this system. Also, this system does not apply to cases where the AF is a secondary condition that occurs in the setting of a primary condition that may be the cause of the AF.</p>
<p>Using this system, it's not always clear what an AF case should be called. For example, a case may fit into the paroxysmal AF category some of the time, while other times it may have the characteristics of persistent AF. One may be able to decide which category is more appropriate by determining which one occurs most often in the case under consideration.</p>
<p>In addition to the four categories in the above system, which are mainly defined by episode timing and termination, the ACC/AHA/ESC guidelines describe additional AF categories in terms of other characteristics of the patient.<sup id="cite_ref-pmid16908781_5-1" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<ul>
<li><i>Lone atrial fibrillation</i> (LAF) - absence of clinical or <a href="/wiki/Echocardiographic" title="Echocardiographic" class="mw-redirect">echocardiographic</a> findings of other <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> (including <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>) or related pulmonary disease, and age under 60&#160;years</li>
<li><i>Nonvalvular AF</i> - absence of <a href="/wiki/Rheumatic_heart_disease" title="Rheumatic heart disease" class="mw-redirect">rheumatic</a> mitral valve disease, a <a href="/wiki/Prosthetic_heart_valve" title="Prosthetic heart valve" class="mw-redirect">prosthetic heart valve</a>, or <a href="/wiki/Mitral_valve_repair" title="Mitral valve repair">mitral valve repair</a></li>
<li><i>Secondary AF</i> - occurs in the setting of a primary condition which may be the cause of the AF, such as <a href="/wiki/Acute_myocardial_infarction" title="Acute myocardial infarction" class="mw-redirect">acute myocardial infarction</a>, <a href="/wiki/Cardiac_surgery" title="Cardiac surgery">cardiac surgery</a>, <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Myocarditis" title="Myocarditis">myocarditis</a>, <a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">hyperthyroidism</a>, <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>, <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, or other acute pulmonary disease</li>
</ul>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>Atrial fibrillation is usually accompanied by symptoms related to a rapid heart rate. Rapid and irregular heart rates may be perceived as <a href="/wiki/Palpitations" title="Palpitations" class="mw-redirect">palpitations</a>, exercise intolerance, and occasionally produce <a href="/wiki/Angina_pectoris" title="Angina pectoris">angina</a> (if the rate is faster and puts the heart under strain) and <a href="/wiki/Heart_failure" title="Heart failure">congestive</a> symptoms of <a href="/wiki/Shortness_of_breath" title="Shortness of breath" class="mw-redirect">shortness of breath</a> or <a href="/wiki/Edema" title="Edema">edema</a>. Sometimes the arrhythmia will be identified only with the onset of a stroke or a <a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">transient ischemic attack</a> (TIA). It is not uncommon for a patient to first become aware of AF from a routine physical examination or <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a>, as it may be asymptomatic in many cases.<sup id="cite_ref-pmid16908781_5-2" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>As most cases of atrial fibrillation are secondary to other medical problems, the presence of <a href="/wiki/Chest_pain" title="Chest pain">chest pain</a> or <a href="/wiki/Angina" title="Angina">angina</a>, symptoms of <a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">hyperthyroidism</a> (an overactive <a href="/wiki/Thyroid_gland" title="Thyroid gland" class="mw-redirect">thyroid gland</a>) such as <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a> and <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, and symptoms suggestive of <a href="/wiki/Lung_disease" title="Lung disease" class="mw-redirect">lung disease</a> would indicate an underlying cause. A previous history of stroke or TIA, as well as <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> (high blood pressure), <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes</a>, <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a> and <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">rheumatic fever</a>, may indicate whether someone with AF is at a higher risk of complications.<sup id="cite_ref-pmid16908781_5-3" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>The evaluation of atrial fibrillation involves diagnosis, determination of the <a href="/wiki/Etiology" title="Etiology">etiology</a> of the arrhythmia, and classification of the arrhythmia. A minimal evaluation should be performed in all individuals with AF. This includes a history and physical examination, <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a>, transthoracic echocardiogram, and routine bloodwork. Certain individuals may benefit from an extended evaluation which may include an evaluation of the heart rate response to exercise, exercise stress testing, a chest x-ray, trans-esophageal echocardiography, and other studies.</p>
<p><a name="Screening" id="Screening"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=4" title="Edit section: Screening">edit</a>]</span> <span class="mw-headline">Screening</span></h3>
<p><a href="/wiki/Screening_(medicine)" title="Screening (medicine)">Screening</a> for atrial fibrillation is not generally performed, although a study of routine pulse checks or <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECGs</a> during routine office visits found that the annual rate of detection of AF in elderly patients improved from 1.04% to 1.63%; selection of patients for prophylactic anticoagulation would improve stroke risk in that age category.<sup id="cite_ref-pmid17673732_7-0" class="reference"><a href="#cite_note-pmid17673732-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p><a name="Routine_primary_care_visit" id="Routine_primary_care_visit"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=5" title="Edit section: Routine primary care visit">edit</a>]</span> <span class="mw-headline">Routine primary care visit</span></h3>
<p>This estimated <a href="/wiki/Sensitivity_(tests)" title="Sensitivity (tests)" class="mw-redirect">sensitivity</a> of the routine primary care visit is 64%. This low result probably reflects the pulse not being checked routinely or carefully.<sup id="cite_ref-pmid17673732_7-1" class="reference"><a href="#cite_note-pmid17673732-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p><a name="Minimal_evaluation" id="Minimal_evaluation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=6" title="Edit section: Minimal evaluation">edit</a>]</span> <span class="mw-headline">Minimal evaluation</span></h3>
<p>The minimal evaluation of atrial fibrillation should generally be performed in all individuals with AF. The goal of this evaluation is to determine the general treatment regimen for the individual. If results of the general evaluation warrant it, further studies may be then performed.</p>
<p><a name="History_and_physical_examination" id="History_and_physical_examination"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=7" title="Edit section: History and physical examination">edit</a>]</span> <span class="mw-headline">History and physical examination</span></h4>
<p>The history of the individual's atrial fibrillation episodes is probably the most important part of the evaluation. Distinctions should be made between those who are entirely asymptomatic when they are in AF (in which case the AF is found as an incidental finding on an <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a> or physical examination) and those who have gross and obvious symptoms due to AF and can pinpoint whenever they go into AF or revert to sinus rhythm.</p>
<p><a name="Routine_bloodwork" id="Routine_bloodwork"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=8" title="Edit section: Routine bloodwork">edit</a>]</span> <span class="mw-headline">Routine bloodwork</span></h4>
<p>While many cases of AF have no definite cause, it may be the result of various other problems (see below). Hence, <a href="/wiki/Renal_function" title="Renal function">renal function</a> and <a href="/wiki/Electrolyte" title="Electrolyte">electrolytes</a> are routinely determined, as well as <a href="/wiki/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">thyroid-stimulating hormone</a> (commonly suppressed in <a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">hyperthyroidism</a> and of relevance if <a href="/wiki/Amiodarone" title="Amiodarone">amiodarone</a> is administered for treatment) and a <a href="/wiki/Complete_blood_count" title="Complete blood count">blood count</a>.<sup id="cite_ref-pmid16908781_5-4" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>In acute-onset AF associated with <a href="/wiki/Chest_pain" title="Chest pain">chest pain</a>, <a href="/wiki/Troponin" title="Troponin">cardiac troponins</a> or other markers of damage to the heart muscle may be ordered. <a href="/wiki/Coagulation" title="Coagulation">Coagulation</a> studies (<a href="/wiki/International_normalized_ratio" title="International normalized ratio" class="mw-redirect">INR</a>/aPTT) are usually performed, as <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a> medication may be commenced.<sup id="cite_ref-pmid16908781_5-5" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Electrocardiogram" id="Electrocardiogram"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=9" title="Edit section: Electrocardiogram">edit</a>]</span> <span class="mw-headline">Electrocardiogram</span></h4>
<div class="thumb tright">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Afib_ecg.jpg" class="image" title="ECG of atrial fibrillation (top) and sinus rhythm (bottom). The purple arrow indicates a P wave, which is lost in atrial fibrillation."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/64/Afib_ecg.jpg/400px-Afib_ecg.jpg" width="400" height="161" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Afib_ecg.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a> of atrial fibrillation (top) and sinus rhythm (bottom). The purple arrow indicates a P wave, which is lost in atrial fibrillation.</div>
</div>
</div>
<p>Atrial fibrillation is diagnosed on an <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">electrocardiogram</a> (ECG), an investigation performed routinely whenever irregular heart beat is suspected. Characteristic findings are the absence of P waves, with unorganized electrical activity in their place, and irregularity of R-R interval due to irregular conduction of impulses to the ventricles.<sup id="cite_ref-pmid16908781_5-6" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>When ECGs are used for screening, the SAFE trial found that electronic software, <a href="/wiki/Primary_care_physician" title="Primary care physician">primary care physicians</a> and the combination of the two had the following sensitivities and specificities:<sup id="cite_ref-pmid17604299_8-0" class="reference"><a href="#cite_note-pmid17604299-8" title=""><span>[</span>9<span>]</span></a></sup>:</p>
<ul>
<li>Interpreted by software: <a href="/wiki/Sensitivity_(tests)" title="Sensitivity (tests)" class="mw-redirect">sensitivity</a> = 83%, <a href="/wiki/Specificity_(tests)" title="Specificity (tests)" class="mw-redirect">specificity</a> = 99%</li>
<li>Interpreted by a primary care physician: sensitivity = 80%, specificity = 92%</li>
<li>Interpreted by a primary care physician with software: sensitivity = 92%, specificity = 91%</li>
</ul>
<p>If paroxysmal AF is suspected but an ECG during an office visit only shows a regular rhythm, AF episodes may be detected and documented with the use of ambulatory <a href="/wiki/Holter_monitor" title="Holter monitor">Holter monitoring</a> (e.g. for a day). If the episodes are too infrequent to be detected by Holter monitoring with reasonable probability, then the patient can be monitored for longer periods (e.g. a month) with an ambulatory <a href="/wiki/Cardiac_event_monitor" title="Cardiac event monitor">event monitor</a>.<sup id="cite_ref-pmid16908781_5-7" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Echocardiography" id="Echocardiography"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=10" title="Edit section: Echocardiography">edit</a>]</span> <span class="mw-headline">Echocardiography</span></h4>
<p>A non-invasive transthoracic <a href="/wiki/Echocardiogram" title="Echocardiogram" class="mw-redirect">echocardiogram</a> (TTE) is generally performed in newly diagnosed AF, as well as if there is a major change in the patient's clinical state. This ultrasound-based scan of the heart may help identify <a href="/wiki/Valvular_heart_disease" title="Valvular heart disease">valvular heart disease</a> (which may greatly increase the risk of stroke), left and right atrial size (which indicates likelihood that AF may become permanent), left ventricular size and function, peak right ventricular pressure (<a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a>), presence of left ventricular hypertrophy and pericardial disease.<sup id="cite_ref-pmid16908781_5-8" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>Significant enlargement of both the left and right atria is associated with long-standing atrial fibrillation and, if noted at the initial presentation of atrial fibrillation, suggests that the atrial fibrillation is likely to be of a longer duration than the individual's symptoms.</p>
<p><a name="Extended_evaluation" id="Extended_evaluation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=11" title="Edit section: Extended evaluation">edit</a>]</span> <span class="mw-headline">Extended evaluation</span></h3>
<p>An extended evaluation is generally not necessary in most individuals with atrial fibrillation, and is only performed if abnormalities are noted in the limited evaluation, if a reversible cause of the atrial fibrillation is suggested, or if further evaluation may change the treatment course.</p>
<p><a name="Chest_X-ray" id="Chest_X-ray"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=12" title="Edit section: Chest X-ray">edit</a>]</span> <span class="mw-headline">Chest X-ray</span></h4>
<p>A <a href="/wiki/Chest_X-ray" title="Chest X-ray" class="mw-redirect">chest X-ray</a> is generally only performed if a pulmonary cause of atrial fibrillation is suggested, or if other cardiac conditions are suspected (particularly <a href="/wiki/Congestive_heart_failure" title="Congestive heart failure" class="mw-redirect">congestive heart failure</a>.) This may reveal an underlying problem in the lungs or the blood vessels in the chest. <sup id="cite_ref-pmid16908781_5-9" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup> In particular, if an underlying pneumonia is suggested, then treatment of the pneumonia may cause the atrial fibrillation to terminate on its own.</p>
<p><a name="Transesophageal_echocardiogram" id="Transesophageal_echocardiogram"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=13" title="Edit section: Transesophageal echocardiogram">edit</a>]</span> <span class="mw-headline">Transesophageal echocardiogram</span></h4>
<p>A normal echocardiography (transthoracic or TTE) has a low sensitivity for identifying <a href="/wiki/Thrombus" title="Thrombus">thrombi</a> (blood clots) in the heart. If this is suspected - e.g. when planning urgent electrical cardioversion - a <a href="/wiki/Echocardiogram#Transesophageal_echocardiogram" title="Echocardiogram" class="mw-redirect">transesophageal echocardiogram</a> (TEE) is preferred.<sup id="cite_ref-pmid16908781_5-10" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>The TEE has much better visualization of the <a href="/wiki/Left_atrial_appendage" title="Left atrial appendage">left atrial appendage</a> than transthoracic echocardiography. This structure, located in the <a href="/wiki/Left_atrium" title="Left atrium">left atrium</a>, is the place where thrombus most commonly is formed in the setting of atrial fibrillation or flutter. TEE has a very high sensitivity for locating thrombus in this area<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since September 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> and can also detect sluggish bloodflow in this area that is suggestive of thrombus formation.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since September 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>If no thrombus is seen on TEE, the incidence of stroke immediately after cardioversion is performed is very low.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since September 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Ambulatory_holter_monitoring" id="Ambulatory_holter_monitoring"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=14" title="Edit section: Ambulatory holter monitoring">edit</a>]</span> <span class="mw-headline">Ambulatory holter monitoring</span></h4>
<p>A <a href="/wiki/Holter_monitor" title="Holter monitor">holter monitor</a> is a wearable ambulatory heart monitor that continuously monitors the heart rate and heart rhythm for a short duration, typically 24 hours. In individuals with symptoms of significant shortness of breath with exertion or palpitations on a regular basis, a holter monitor may be of benefit to determine if rapid heart rates (or unusually slow heart rates) during atrial fibrillation are the cause of the symptoms.</p>
<p><a name="Exercise_stress_testing" id="Exercise_stress_testing"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=15" title="Edit section: Exercise stress testing">edit</a>]</span> <span class="mw-headline">Exercise stress testing</span></h4>
<p>Some individuals with atrial fibrillation do well with normal activity but develop shortness of breath with exertion. It may be unclear if the shortness of breath is due to a blunted heart rate response to exertion due to excessive AV node blocking agents, a very rapid heart rate during exertion, or due to other underlying conditions such as chronic lung disease or coronary ischemia. An <a href="/wiki/Cardiac_stress_test" title="Cardiac stress test">exercise stress test</a> will evaluate the individual's heart rate response to exertion and determine if the AV node blocking agents are contributing to the symptoms.</p>
<p><a name="Etiology" id="Etiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=16" title="Edit section: Etiology">edit</a>]</span> <span class="mw-headline">Etiology</span></h2>
<p>AF is linked to several cardiac causes, but may occur in otherwise normal hearts. Known associations include:</p>
<ul>
<li><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a> (High blood pressure)</li>
<li>Primary heart diseases including <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a>, <a href="/wiki/Mitral_stenosis" title="Mitral stenosis">mitral stenosis</a> (e.g. due to <a href="/wiki/Rheumatic_heart_disease" title="Rheumatic heart disease" class="mw-redirect">rheumatic heart disease</a> or <a href="/wiki/Mitral_valve_prolapse" title="Mitral valve prolapse">mitral valve prolapse</a>), <a href="/wiki/Mitral_regurgitation" title="Mitral regurgitation">mitral regurgitation</a>, <a href="/wiki/Hypertrophic_cardiomyopathy" title="Hypertrophic cardiomyopathy">hypertrophic cardiomyopathy</a> (HCM), <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Congenital_heart_disease" title="Congenital heart disease" class="mw-redirect">congenital heart disease</a>, previous <a href="/wiki/Heart_surgery" title="Heart surgery" class="mw-redirect">heart surgery</a></li>
<li>Lung diseases (such as <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a>, <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>, <a href="/wiki/Sarcoidosis" title="Sarcoidosis">sarcoidosis</a>)</li>
<li>Excessive <a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">alcohol</a> consumption ("<a href="/wiki/Binge_drinking" title="Binge drinking">binge drinking</a>" or "<a href="/wiki/Holiday_heart_syndrome" title="Holiday heart syndrome">holiday heart syndrome</a>"). Even otherwise healthy middle-aged women who consumed more than 2 drinks daily were 60% more likely to develop AF.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li><a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">Hyperthyroidism</a></li>
<li><a href="/wiki/Carbon_monoxide_poisoning" title="Carbon monoxide poisoning">Carbon monoxide poisoning</a></li>
<li>Dual-chamber <a href="/wiki/Pacemaker" title="Pacemaker" class="mw-redirect">pacemakers</a> in the presence of normal atrioventricular conduction.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup></li>
<li>A family history of AF may increases the risk of AF. A study of more than 2,200 AF patients found that 30 per cent had parents with AF.<sup id="cite_ref-pmid15199036_11-0" class="reference"><a href="#cite_note-pmid15199036-11" title=""><span>[</span>12<span>]</span></a></sup> Various genetic mutations may be responsible.<sup id="cite_ref-pmid16790707_12-0" class="reference"><a href="#cite_note-pmid16790707-12" title=""><span>[</span>13<span>]</span></a></sup></li>
</ul>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=17" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<p><a name="Morphology" id="Morphology"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=18" title="Edit section: Morphology">edit</a>]</span> <span class="mw-headline">Morphology</span></h3>
<p>The primary pathologic change seen in atrial fibrillation is the progressive fibrosis of the atria. This fibrosis is primarily due to atrial dilation, however genetic causes and inflammation may have a cause in some individuals.</p>
<p>Dilation of the atria can be due to almost any structural abnormality of the heart that can cause a rise in the intra-cardiac pressures. This includes valvular heart disease (such as mitral stenosis, mitral regurgitation, and tricuspid regurgitation), hypertension, and congestive heart failure. Any inflammatory state that affects the heart can cause fibrosis of the atria. This is typically due to sarcoidosis but may also be due to autoimmune disorders that create autoantibodies against myosin heavy chains. Mutation of the <i><a href="/wiki/Lamin" title="Lamin">lamin</a> AC</i> gene is also associated with fibrosis of the atria that can lead to atrial fibrillation.</p>
<p>Once dilation of the atria has occurred, this begins a chain of events that leads to the activation of the <a href="/wiki/Renin-angiotensin_system" title="Renin-angiotensin system">renin aldosterone angiotensin system</a> (RAAS) and subsequent increase in matrix metaloproteinases and disintegrin, which leads to atrial remodeling and fibrosis, with loss of atrial muscle mass.</p>
<p>This process is not immediate, and experimental studies have revealed patchy atrial fibrosis may precede the occurrence of atrial fibrillation and may progress with prolonged durations of atrial fibrillation.</p>
<p>Fibrosis is not limited to the muscle mass of the atria, and may occur in the <a href="/wiki/Sinus_node" title="Sinus node" class="mw-redirect">sinus node</a> (SA node) and <a href="/wiki/Atrioventricular_node" title="Atrioventricular node">atrioventricular node</a> (AV node), correlating with <a href="/wiki/Sick_sinus_syndrome" title="Sick sinus syndrome">sick sinus syndrome</a>. Prolonged episodes of atrial fibrillation have been shown to correlate with prolongation of the sinus node recovery time,<sup id="cite_ref-pmid16908781_5-11" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup> <sup id="cite_ref-pmid8941126_13-0" class="reference"><a href="#cite_note-pmid8941126-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-pmid11469431_14-0" class="reference"><a href="#cite_note-pmid11469431-14" title=""><span>[</span>15<span>]</span></a></sup> suggesting that dysfunction of the SA node is progressive with prolonged episodes of atrial fibrillation.</p>
<p><a name="Electrophysiology" id="Electrophysiology"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=19" title="Edit section: Electrophysiology">edit</a>]</span> <span class="mw-headline">Electrophysiology</span></h3>
<table border="1" style="border-collapse:collapse" cellpadding="3" align="right">
<tr>
<td colspan="3" align="center" bgcolor="#ABCDEF">Conduction</td>
</tr>
<tr>
<td><small>Sinus rhythm</small>
<div class="floatnone"><a href="/wiki/File:Heart_conduct_sinus.gif" class="image" title="Heart conduct sinus.gif"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/c/c3/Heart_conduct_sinus.gif" width="230" height="217" border="0" /></a></div>
</td>
<td><small>Atrial fibrillation</small>
<div class="floatnone"><a href="/wiki/File:Heart_conduct_atrialfib.gif" class="image" title="Heart conduct atrialfib.gif"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/4/44/Heart_conduct_atrialfib.gif" width="230" height="217" border="0" /></a></div>
</td>
</tr>
</table>
<p>The normal <a href="/wiki/Electrical_conduction_system_of_the_heart" title="Electrical conduction system of the heart">electrical conduction system of the heart</a> allows the impulse that is generated by the <a href="/wiki/Sinoatrial_node" title="Sinoatrial node">sinoatrial node</a> (SA node) of the heart to be propagated to and stimulate the <a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">myocardium</a> (muscle of the heart). When the myocardium is stimulated, it contracts. It is the ordered stimulation of the myocardium that allows efficient contraction of the heart, thereby allowing blood to be pumped to the body.</p>
<p>In atrial fibrillation, the regular impulses produced by the sinus node to provide rhythmic contraction of the heart are overwhelmed by the rapid randomly generated electrical discharges produced by larger areas of atrial tissue, often localized to the <a href="/wiki/Pulmonary_vein" title="Pulmonary vein">pulmonary veins</a>. It can be distinguished from <a href="/wiki/Atrial_flutter" title="Atrial flutter">atrial flutter</a>, which is a more organized electrical circuit usually in the right atrium that produces characteristic saw-toothed p-waves on the <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a>; in atrial flutter, the discharges circulate rapidly at a rate of 300&#160;beats per minute (bpm) around the atrium; in AF, there is no regularity of this kind at all.</p>
<p><a name="Thromboembolism" id="Thromboembolism"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=20" title="Edit section: Thromboembolism">edit</a>]</span> <span class="mw-headline">Thromboembolism</span></h3>
<p>In atrial fibrillation, the lack of an organized atrial contraction can result in stagnant blood, especially in the <a href="/wiki/Left_atrial_appendage" title="Left atrial appendage">left atrial appendage</a> (LAA). Stagnant blood can result in a <a href="/wiki/Coagulation" title="Coagulation">clot</a>, which is called a <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> while it is immobile at its place of origin. If the clot becomes mobile and is carried away by the blood circulation, it is called an <a href="/wiki/Embolus" title="Embolus" class="mw-redirect">embolus</a>. When an embolus from the LAA leaves the heart, it proceeds through smaller and smaller <a href="/wiki/Artery" title="Artery">arteries</a> until it plugs one of them. A <a href="/wiki/Thromboembolism" title="Thromboembolism" class="mw-redirect">thromboembolism</a> is said to occur when a thrombus that became an embolus plugs a blood vessel and prevents blood from flowing. The damage produced by an embolus is related to where the circulation takes it. An embolus that ends up in the brain produces the most feared complication of atrial fibrillation, namely <a href="/wiki/Stroke" title="Stroke">stroke</a>, while an embolus may also lodge in the mesenteric circulation (the circulation supplying the abdominal organs) or digit, producing organ-specific damage such as <a href="/wiki/Bowel_ischemia" title="Bowel ischemia" class="mw-redirect">bowel ischemia</a> or ischemia of the fingers or toes.</p>
<p>The LAA lies in close relation to the free wall of the left ventricle and thus the LAA's emptying and filling, which determines its degree of blood stagnation, may be significantly affected by left ventricular function.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=21" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>The main goals of treatment of atrial fibrillation are to prevent temporary circulatory instability and to prevent <a href="/wiki/Stroke" title="Stroke">stroke</a>. Rate and rhythm control are principally used to achieve the former, while <a href="/wiki/Anticoagulation" title="Anticoagulation" class="mw-redirect">anticoagulation</a> may be required to decrease the risk of the latter.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup> In emergencies, when circulatory collapse is imminent due to uncontrolled <a href="/wiki/Tachycardia" title="Tachycardia">tachycardia</a>, immediate <a href="/wiki/Cardioversion" title="Cardioversion">cardioversion</a> may be indicated.<sup id="cite_ref-pmid16908781_5-12" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>The primary factors determining atrial fibrillation treatment are duration and evidence of hemodynamic instability. <a href="/wiki/Cardioversion" title="Cardioversion">Cardioversion</a> is indicated with new onset AF (for less than 48 hours) and with hemodynamic instability. If rate and rhythm control can not be maintained by medication or cardioversion, <a href="/wiki/Cardiac_electrophysiology" title="Cardiac electrophysiology">electrophysiological studies</a> with pathway <a href="/wiki/Radiofrequency_ablation" title="Radiofrequency ablation">ablation</a> may be required.<sup id="cite_ref-pmid16908781_5-13" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Anticoagulation" id="Anticoagulation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=22" title="Edit section: Anticoagulation">edit</a>]</span> <span class="mw-headline">Anticoagulation</span></h3>
<p>Most patients with AF are at increased risk of stroke. The possible exceptions are those with lone AF (LAF).<sup id="cite_ref-pmid17548732_3-1" class="reference"><a href="#cite_note-pmid17548732-3" title=""><span>[</span>4<span>]</span></a></sup> A <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> of risk factors for <a href="/wiki/Stroke" title="Stroke">stroke</a> in patients with nonvalvular atrial fibrillation concluded that a prior history of stroke or TIA is the most powerful risk factor for future stroke, followed by advancing age, hypertension, and diabetes.<sup id="cite_ref-pmid17679673_17-0" class="reference"><a href="#cite_note-pmid17679673-17" title=""><span>[</span>18<span>]</span></a></sup> For patients with LAF, the risk of stroke is very low and is independent of whether the LAF was an isolated episode, paroxysmal, persistent, or permanent.<sup id="cite_ref-pmid3627174_18-0" class="reference"><a href="#cite_note-pmid3627174-18" title=""><span>[</span>19<span>]</span></a></sup> The risk of systemic embolization (atrial clots migrating to other organs) depends strongly on whether there is an underlying structural problem with the heart (e.g. <a href="/wiki/Mitral_stenosis" title="Mitral stenosis">mitral stenosis</a>) and on the presence of other risk factors, such as diabetes and high blood pressure. Finally, patients under 65 are much less likely to develop embolization compared with patients over 75. In young patients with few risk factors and no structural heart defect, the benefits of anticoagulation may be outweighed by the risks of <a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">hemorrhage</a> (bleeding). Those at a low risk may benefit from mild (and low-risk) anticoagulation with <a href="/wiki/Aspirin" title="Aspirin">aspirin</a> (or <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a> in those who are allergic to aspirin). In contrast, those with a high risk of stroke derive most benefit from <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a> treatment with <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> or similar drugs.</p>
<p>In the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, the <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">NICE</a> guidelines recommend using a <a href="/wiki/Clinical_prediction_rule" title="Clinical prediction rule">clinical prediction rule</a> for this purpose.<sup id="cite_ref-nice_19-0" class="reference"><a href="#cite_note-nice-19" title=""><span>[</span>20<span>]</span></a></sup> The <i><a href="/wiki/CHADS_Score" title="CHADS Score">CHADS<sub>2</sub></a></i> score is the best validated clinical prediction rule for determining the risk of stroke (and therefore who should and should not be anticoagulated with <a href="/wiki/Warfarin" title="Warfarin">warfarin</a>); it assigns points (totaling 0-6) depending on the presence or absence of co-morbidities such as hypertension and diabetes. In a comparison of seven prediction rules, the best was <a href="/wiki/CHADS_Score" title="CHADS Score">CHADS<sub>2</sub></a> which performed similarly to the SPAF<sup id="cite_ref-pmid10356104_20-0" class="reference"><a href="#cite_note-pmid10356104-20" title=""><span>[</span>21<span>]</span></a></sup> and <a href="/wiki/Framingham_Heart_Study" title="Framingham Heart Study">Framingham</a><sup id="cite_ref-pmid12941677_21-0" class="reference"><a href="#cite_note-pmid12941677-21" title=""><span>[</span>22<span>]</span></a></sup> prediction rules. <sup id="cite_ref-pmid17673721_22-0" class="reference"><a href="#cite_note-pmid17673721-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p>To compensate for the increased risk of stroke, anticoagulants may be required. However, in the case of warfarin, if someone with AF has a yearly risk of stroke that is less than 2%, then the risks associated with taking warfarin outweigh the risk of getting a stroke from AF.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup></p>
<p>Atrial fibrillation in the context of mitral stenosis is associated with a seventeen-fold increase in stroke risk.<sup id="cite_ref-Wolf1978_4-1" class="reference"><a href="#cite_note-Wolf1978-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a name="Acute_anticoagulation" id="Acute_anticoagulation"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=23" title="Edit section: Acute anticoagulation">edit</a>]</span> <span class="mw-headline">Acute anticoagulation</span></h4>
<p>If anticoagulation is required urgently (e.g. for cardioversion), <a href="/wiki/Heparin" title="Heparin">heparin</a> or similar drugs achieve the required level of protection much quicker than warfarin, which will take several days to reach adequate levels.</p>
<p>In the initial stages after an embolic stroke, anticoagulation may be risky, as the damaged area of the brain is relatively prone to bleeding (hemorrhagic transformation).<sup id="cite_ref-pmid17204681_25-0" class="reference"><a href="#cite_note-pmid17204681-25" title=""><span>[</span>26<span>]</span></a></sup> As a result, a <a href="/wiki/Clinical_practice_guideline" title="Clinical practice guideline" class="mw-redirect">clinical practice guideline</a> by <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a> recommends that anticoagulation should begin two weeks after stroke if no hemorrhage occurred.<sup id="cite_ref-nice_19-1" class="reference"><a href="#cite_note-nice-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>In cases of chronic stable atrial fibrillation without any other risk factors for thromboembolism, the Seventh American College of Chest Physicians (ACCP) Conference on Antithrombotic and Thrombolytic Therapy recommends initiating warfarin without heparin bridging. <sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> While there is a theoretical concern of causing a transient prothrombotic state with the initiation of warfarin, a study comparing the initiation of warfarin alone with warfarin and <a href="/wiki/Low_molecular_weight_heparin" title="Low molecular weight heparin">low molecular weight heparin</a> shows no significant difference in the concentrations of endogenous anticoagulants or in markers of active clot formation.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup></p>
<p><a name="Chronic_anticoagulation" id="Chronic_anticoagulation"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=24" title="Edit section: Chronic anticoagulation">edit</a>]</span> <span class="mw-headline">Chronic anticoagulation</span></h4>
<p>Among patients with "non-valvular" atrial fibrillation, anticoagulation with warfarin can reduce stroke by 60% while antiplatelet agents can reduce stroke by 20%. <sup id="cite_ref-pmid17577005_28-0" class="reference"><a href="#cite_note-pmid17577005-28" title=""><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-pmid17636831_29-0" class="reference"><a href="#cite_note-pmid17636831-29" title=""><span>[</span>30<span>]</span></a></sup>. There is evidence that <a href="/wiki/Aspirin" title="Aspirin">aspirin</a> and <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a> are effective when used together, but the combination is still inferior to <a href="/wiki/Warfarin" title="Warfarin">warfarin</a>.<sup id="cite_ref-pmid16765759_30-0" class="reference"><a href="#cite_note-pmid16765759-30" title=""><span>[</span>31<span>]</span></a></sup></p>
<p>Warfarin treatment requires frequent monitoring with a blood test called the <a href="/wiki/Prothrombin_time" title="Prothrombin time">international normalized ratio</a> (INR); this determines whether the correct dose is being used. In atrial fibrillation, the usual target INR is between 2.0 and 3.0 (higher targets are used in patients with mechanical <a href="/wiki/Artificial_heart_valve" title="Artificial heart valve">artificial heart valves</a>, many of whom may also have atrial fibrillation). A high INR may indicate increased bleeding risk, while a low INR would indicate that there is insufficient protection from stroke.</p>
<p>An attempt was made to find a better method of implementing warfarin therapy without the inconvenience of regular monitoring and risk of intracranial hemorrhage. A combination of aspirin and fixed-dose warfarin (initial INR 1.2-1.5) was tried. Unfortunately, in a study of AF patients with additional risk factors for thromboembolism, the combination of aspirin and the lower dose of warfarin was significantly inferior to the standard adjusted-dose warfarin (INR 2.0-3.0), yet still had a similar risk of intracranial hemorrhage.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p><a name="Elderly_patients" id="Elderly_patients"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=25" title="Edit section: Elderly patients">edit</a>]</span> <span class="mw-headline">Elderly patients</span></h4>
<p>The very elderly (patients aged 75&#160;years or more) may benefit from anticoagulation provided that their anticoagulation does not increase hemorrhagic complications, which is a difficult goal. Patients aged 80&#160;years or more may be especially susceptible to bleeding complications, with a rate of 13&#160;bleeds per 100&#160;person-years.<sup id="cite_ref-pmid17515465_32-0" class="reference"><a href="#cite_note-pmid17515465-32" title=""><span>[</span>33<span>]</span></a></sup> This bleed rate would seem to preclude use of warfarin; however, a <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trial</a> found benefit in treating patients 75&#160;years or over with a <a href="/wiki/Number_needed_to_treat" title="Number needed to treat">number needed to treat</a> of 50.<sup id="cite_ref-pmidpendingMant_33-0" class="reference"><a href="#cite_note-pmidpendingMant-33" title=""><span>[</span>34<span>]</span></a></sup> Of note, this study had very low rate of hemorrhagic complications in the warfarin group.</p>
<p><a name="Cardioversion" id="Cardioversion"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=26" title="Edit section: Cardioversion">edit</a>]</span> <span class="mw-headline">Cardioversion</span></h3>
<p><a href="/wiki/Cardioversion" title="Cardioversion">Cardioversion</a> is a noninvasive conversion of an irregular heartbeat to a normal heartbeat using electrical or chemical means:<sup id="cite_ref-pmid16908781_5-14" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<ul>
<li><i>Electrical cardioversion</i> involves the restoration of normal heart rhythm through the application of a DC electrical shock.</li>
<li><i>Chemical cardioversion</i> is performed with drugs, such as <a href="/wiki/Amiodarone" title="Amiodarone">amiodarone</a>, <a href="/wiki/Dronedarone" title="Dronedarone">dronedarone</a><sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup>, <a href="/wiki/Procainamide" title="Procainamide">procainamide</a>, <a href="/wiki/Ibutilide" title="Ibutilide">ibutilide</a>, <a href="/wiki/Propafenone" title="Propafenone">propafenone</a> or <a href="/wiki/Flecainide" title="Flecainide">flecainide</a>.</li>
</ul>
<p>The main risk of cardioversion is systemic embolization of a <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> (blood clot) from the previously fibrillating left atrium. Cardioversion should not be performed without adequate anticoagulation in patients with more than 48 hours of atrial fibrillation. Cardioversion may be performed in instances of AF lasting more than 48&#160;hours if a <a href="/wiki/Transesophogeal_echocardiogram" title="Transesophogeal echocardiogram" class="mw-redirect">transesophogeal echocardiogram</a> (TEE) demonstrates no evidence of clot within the heart.<sup id="cite_ref-pmid16908781_5-15" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>Whichever method of cardioversion is used, approximately 50% of patients <a href="/wiki/Relapse" title="Relapse">relapse</a> within one year, although the continued daily use of oral antiarrhythmic drugs may extend this period. The key risk factor for relapse is duration of AF, although other risk factors that have been identified include the presence of structural heart disease, and increasing age.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Rate_control_versus_rhythm_control_using_drugs" id="Rate_control_versus_rhythm_control_using_drugs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=27" title="Edit section: Rate control versus rhythm control using drugs">edit</a>]</span> <span class="mw-headline">Rate control versus rhythm control using drugs</span></h3>
<p>AF can cause disabling and annoying symptoms. <a href="/wiki/Palpitations" title="Palpitations" class="mw-redirect">Palpitations</a>, <a href="/wiki/Angina_pectoris" title="Angina pectoris">angina</a>, lassitude (weariness), and decreased exercise tolerance are related to rapid heart rate and inefficient cardiac output caused by AF. Furthermore, AF with a persistent rapid rate can cause a form of <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a> called <a href="/wiki/Tachycardia_induced_cardiomyopathy" title="Tachycardia induced cardiomyopathy">tachycardia induced cardiomyopathy</a>. This can significantly increase mortality and morbidity, which can be prevented by early and adequate treatment of the AF.</p>
<p>There are two ways to approach these symptoms using drugs: rate control and rhythm control. <i>Rate control</i> seeks to reduce the heart rate to one that is closer to normal, usually 60 to 100&#160;bpm, without trying to convert to a regular rhythm. <i>Rhythm control</i> seeks to restore with <a href="/wiki/Cardioversion" title="Cardioversion">cardioversion</a> the regular heart rhythm and maintain it with drugs. Studies suggest that rhythm control is mainly a concern in newly diagnosed AF, while rate control is more important in the chronic phase. Rate control with anticoagulation is as effective a treatment as rhythm control in long term mortality studies, the AFFIRM Trial.<sup id="cite_ref-pmid12466506_35-0" class="reference"><a href="#cite_note-pmid12466506-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p>The AFFIRM study showed no difference in risk of stroke in patients who have converted to a normal rhythm with anti-arrhythmic treatment, compared to those who have only rate control.<sup id="cite_ref-pmid12466506_35-1" class="reference"><a href="#cite_note-pmid12466506-35" title=""><span>[</span>36<span>]</span></a></sup> AF is associated with a reduced quality of life, and while some studies indicate that rhythm control leads to a higher quality of life, the AFFIRM study did not find a difference.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p>A further study focused on rhythm control in patients with AF and simultaneous heart failure, based on the premise that AF confers a higher mortality risk in heart failure. In this setting, too, rhythm control offered no advantage compared to rate control.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup></p>
<p>In patients with a fast ventricular response, intravenous <a href="/wiki/Magnesium" title="Magnesium">magnesium</a> significantly increases the chances of successful rate and rhythm control in the urgent setting without significant side-effects.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p><a name="Rate_control" id="Rate_control"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=28" title="Edit section: Rate control">edit</a>]</span> <span class="mw-headline">Rate control</span></h3>
<p>Rate control is achieved with medications that work by increasing the degree of block at the level of the AV node, effectively decreasing the number of impulses that conduct down into the ventricles. This can be done with:<sup id="cite_ref-pmid16908781_5-16" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Beta_blockers" title="Beta blockers" class="mw-redirect">Beta blockers</a> (preferably the "cardioselective" beta blockers such as <a href="/wiki/Metoprolol" title="Metoprolol">metoprolol</a>, <a href="/wiki/Atenolol" title="Atenolol">atenolol</a>, <a href="/wiki/Bisoprolol" title="Bisoprolol">bisoprolol</a>)</li>
<li><a href="/wiki/Cardiac_glycosides" title="Cardiac glycosides" class="mw-redirect">Cardiac glycosides</a> (i.e. <a href="/wiki/Digoxin" title="Digoxin">digoxin</a>)</li>
<li><a href="/wiki/Calcium_channel_blocker" title="Calcium channel blocker">Calcium channel blockers</a> (i.e. <a href="/wiki/Diltiazem" title="Diltiazem">diltiazem</a> or <a href="/wiki/Verapamil" title="Verapamil">verapamil</a>)</li>
</ul>
<p>In addition to these agents, <a href="/wiki/Amiodarone" title="Amiodarone">amiodarone</a> has some AV node blocking effects (particularly when administered intravenously), and can be used in individuals when other agents are contraindicated or ineffective (particularly due to hypotension).</p>
<p><a name="Maintenance_of_sinus_rhythm" id="Maintenance_of_sinus_rhythm"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=29" title="Edit section: Maintenance of sinus rhythm">edit</a>]</span> <span class="mw-headline">Maintenance of sinus rhythm</span></h3>
<p>The mainstay of maintaining sinus rhythm is the use of antiarrhythmic agents. Recently, other approaches have been developed that promise to decrease or eliminate the need for antiarrhythmic agents.</p>
<p><a name="Antiarrhythmic_agents" id="Antiarrhythmic_agents"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=30" title="Edit section: Antiarrhythmic agents">edit</a>]</span> <span class="mw-headline">Antiarrhythmic agents</span></h4>
<p>The <a href="/wiki/Antiarrhythmic_agent" title="Antiarrhythmic agent">anti-arrhythmic medications</a> often used in either pharmacological cardioversion or in the prevention of relapse to AF alter the flux of ions in heart tissue, making them less excitable, setting the stage for spontaneous and durable cardioversion. These medications are often used in concert with electrical cardioversion.</p>
<p><a name="Catheter_ablation" id="Catheter_ablation"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=31" title="Edit section: Catheter ablation">edit</a>]</span> <span class="mw-headline">Catheter ablation</span></h4>
<p>In patients with AF where rate control drugs are ineffective and it is not possible to restore sinus rhythm using cardioversion, non-pharmacological alternatives are available. For example, to control rate it is possible to destroy the bundle of cells connecting the upper and lower chambers of the heart - the <a href="/wiki/Atrioventricular_node" title="Atrioventricular node">atrioventricular node</a> - which regulates heart rate, and to implant a <a href="/wiki/Artificial_pacemaker" title="Artificial pacemaker">pacemaker</a> instead. A more complex technique, which avoids the need for a pacemaker, involves ablating groups of cells near the pulmonary veins where atrial fibrillation is thought to originate, or creating more extensive lesions in an attempt to prevent atrial fibrillation from establishing itself.<sup id="cite_ref-pmid16908781_5-17" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a href="/wiki/Ablation" title="Ablation">Ablation</a> is a technique that has shown some promise for cases of recurrent AF that are unresponsive to conventional treatments. <a href="/wiki/Radiofrequency_ablation" title="Radiofrequency ablation">Radiofrequency ablation</a> (RFA) uses radiofrequency energy to destroy abnormal electrical pathways in heart tissue. Other energy sourses include laser, cryothermy and high intensity ultrasound. The energy emitting probe (<a href="/wiki/Electrode" title="Electrode">electrode</a>) is placed into the heart through a <a href="/wiki/Catheter" title="Catheter">catheter</a> inserted into veins in the groin or neck. Electrodes that can detect electrical activity from inside the heart are also inserted, and the electrophysiologist uses these to "map" an area of the heart in order to locate the abnormal electrical activity before eliminating the responsible tissue.</p>
<p>Most AF ablations consist of isolating the electrical pathways from the <a href="/wiki/Pulmonary_vein" title="Pulmonary vein">pulmonary veins</a> (PV)<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup>, which are located on the posterior wall of the left atrium. All other veins from the body (including neck and groin) lead to the right atrium, so in order to get to the left atrium the catheters must get across the atrial septum. This is done by piercing a small hole in the septal wall. This is called a transseptal approach. Once in the left atrium, the physician may perform <i>Wide Area Circumferential Ablation</i> (WACA) to electrically isolate the PVs from the left atrium.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>Some more recent approaches to ablating AF is to target sites that are particularly disorganized in both atria as well as in the <a href="/wiki/Coronary_sinus" title="Coronary sinus">coronary sinus</a> (CS). These sites are termed <i>complex fractionated atrial electrogram</i> (CFAE) sites.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup>. It is believed by some that the CFAE sites are the cause of AF, or a combination of the PVs and CFAE sites are to blame. New techniques include the use of <a href="/wiki/Cryoablation" title="Cryoablation">cryoablation</a> (tissue freezing using a coolant which flows through the catheter), microwave ablation, where tissue is ablated by the microwave energy "cooking" the adjacent tissue, and high intensity focused ultrasound (HIFU), which destroys tissue by heating. This is an area of active research, especially with respect to the RF ablation technique and emphasis on isolating the pulmonary veins that enter into the left atrium.</p>
<p>Efficacy and risks of catheter ablation of atrial fibrillation are areas of active debate. A worldwide survey of the outcomes of 8745 ablation procedures<sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup> demonstrated a 52% success rate (ranging from 14.5% to 76.5% among centers), with an additional 23.9% of patients becoming asymptomatic with addition of an antiarrhythmic medication. In 27.3% of patients, more than one procedure was required to attain these results. There was at least one major complication in 6% of patients. A thorough discussion of results of catheter ablation was published in 2007<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup>; it notes that results are widely variable, due in part to differences in technique, follow-up, definitions of success, use of antiarrhythmic therapy, and in experience and technical proficiency.</p>
<p><a name="Cox_maze" id="Cox_maze"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=32" title="Edit section: Cox maze">edit</a>]</span> <span class="mw-headline">Cox maze</span></h4>
<p>The <a href="/wiki/Cox_maze_procedure" title="Cox maze procedure">Cox maze procedure</a> is an open-heart surgical procedure intended to eliminate atrial fibrillation and was first performed in 1987. "Maze" refers to the series of incisions made in the atria, which are arranged in a maze-like pattern. The intention was to eliminate AF by using incisional scars to block abnormal electrical circuits (atrial macroreentry) that AF requires. This procedure required an extensive series of endocardial (from the inside of the heart) incisions through both atria, a median sternotomy (vertical incision through the breastbone) and cardiopulmonary bypass (heart-lung machine). A series of improvements were made, culminating in 1992 in the Cox maze III procedure, which is now considered to be the "gold standard" for effective surgical cure of AF. The Cox maze III is sometimes referred to as the "traditional maze", the "cut and sew maze", or simply the "maze".<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p><a name="Minimally_invasive_maze_procedures" id="Minimally_invasive_maze_procedures"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=33" title="Edit section: Minimally invasive maze procedures">edit</a>]</span> <span class="mw-headline">Minimally invasive maze procedures</span></h4>
<p><a href="/wiki/Minimaze" title="Minimaze" class="mw-redirect">Minimaze</a> procedures are minimally invasive versions of the original <a href="/wiki/Cox_maze_procedure" title="Cox maze procedure">Cox maze procedure</a> but without cardiac incisions. These procedures do not require a median sternotomy (vertical incision in the breastbone) or <a href="/wiki/Cardiopulmonary_bypass" title="Cardiopulmonary bypass">cardiopulmonary bypass</a> (heart-lung machine). They use laser, cryothermy, radiofrequency, or acoustic energy to ablate atrial tissue near the pulmonary veins and make other required ablations to mimic the maze.</p>
<p>Minimally invasive surgical (<a href="/wiki/Endoscopic" title="Endoscopic" class="mw-redirect">endoscopic</a>) maze procedures are now routinely conducted at hospitals around the US. This approach was developed in the early 2000s.<sup id="cite_ref-Saltman2003_45-0" class="reference"><a href="#cite_note-Saltman2003-45" title=""><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-rwjHosp_46-0" class="reference"><a href="#cite_note-rwjHosp-46" title=""><span>[</span>47<span>]</span></a></sup></p>
<p>The Ex-Maze is a minimally invasive procedure, first reported in 2007, that also creates a lesion pattern across both atria epicardially on the beating heart.<sup id="cite_ref-ex-maze_47-0" class="reference"><a href="#cite_note-ex-maze-47" title=""><span>[</span>48<span>]</span></a></sup> As with other procedures off-bypass, the surgeon can confirm that atrial fibrillation corrects to normal sinus rhythm during the procedure.<sup id="cite_ref-pattern_48-0" class="reference"><a href="#cite_note-pattern-48" title=""><span>[</span>49<span>]</span></a></sup> Laparoscopic instruments are used to access the pericardium through the diaphragm. Like many heart-cauterizing instruments, the Ex-Maze device uses heat generated by a radiofrequency coil. The coil is inside a plastic tube that uses suction to maintain contact against the beating heart’s surface.<sup id="cite_ref-pattern1_49-0" class="reference"><a href="#cite_note-pattern1-49" title=""><span>[</span>50<span>]</span></a></sup></p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=34" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>Atrial fibrillation is the most common arrhythmia found in clinical practice.<sup id="cite_ref-pmid16908781_5-18" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup> It also accounts for 1/3 of hospital admissions for cardiac rhythm disturbances<sup id="cite_ref-pmid16908781_5-19" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup>, and the rate of admissions for AF has risen in recent years.<sup id="cite_ref-Friberg-2003_50-0" class="reference"><a href="#cite_note-Friberg-2003-50" title=""><span>[</span>51<span>]</span></a></sup> Approximately 2.2&#160;million individuals in the United States and 4.5&#160;million in the European Union have AF.<sup id="cite_ref-pmid16908781_5-20" class="reference"><a href="#cite_note-pmid16908781-5" title=""><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup></p>
<p>The incidence of atrial fibrillation increases with age. The prevalence in individuals over the age of 80 is about 8%.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup> In developed countries, the number of patients with atrial fibrillation is likely to increase during the next 50&#160;years, due to the growing proportion of elderly individuals.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=35" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Because the diagnosis of atrial fibrillation requires measurement of the electrical activity of the heart, atrial fibrillation was not truly described until 1874, when <a href="/wiki/Edm%C3%A9_F%C3%A9lix_Alfred_Vulpian" title="Edmé Félix Alfred Vulpian" class="mw-redirect">Edmé Félix Alfred Vulpian</a> observed the irregular atrial electrical behavior that he termed <i>"fremissement fibrillaire"</i> in dog hearts.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup> In the mid-eighteenth century, <a href="/wiki/Jean-Baptiste_de_S%C3%A9nac" title="Jean-Baptiste de Sénac">Jean-Baptiste de Sénac</a> made note of dilated, irritated atria in people with <a href="/wiki/Mitral_stenosis" title="Mitral stenosis">mitral stenosis</a>.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup> The irregular pulse associated with AF was first recorded in 1876 by <a href="/wiki/Carl_Nothnagel" title="Carl Nothnagel">Carl Wilhelm Hermann Nothnagel</a> and termed <i>"delirium cordis"</i>, stating that "[I]n this form of arrhythmia the heartbeats follow each other in complete irregularity. At the same time, the height and tension of the individual pulse waves are continuously changing".<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup> Correlation of delirium cordis with the loss of atrial contraction as reflected in the loss of <i>a waves</i> in the <a href="/wiki/Jugular_venous_pressure" title="Jugular venous pressure">jugular venous pulse</a> was made by Sir James MacKenzie in 1904.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup> <a href="/wiki/Willem_Einthoven" title="Willem Einthoven">Willem Einthoven</a> published the first <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a> showing AF in 1906.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup> The connection between the anatomic and electrical manifestations of AF and the irregular pulse of delirium cordis was made in 1909 by Carl Julius Rothberger, Heinrich Winterberg, and Sir Thomas Lewis.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup><sup id="cite_ref-61" class="reference"><a href="#cite_note-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=36" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Atrial_flutter" title="Atrial flutter">Atrial flutter</a></li>
<li><a href="/wiki/Ashman_phenomenon" title="Ashman phenomenon">Ashman phenomenon</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=37" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-AHAafibForProfessionals-0"><b><a href="#cite_ref-AHAafibForProfessionals_0-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.webcitation.org/5fcMx8BUx" class="external text" title="http://www.webcitation.org/5fcMx8BUx" rel="nofollow">"Atrial Fibrillation (for Professionals)"</a>. American Heart Association, Inc.. 2008-12-04. Archived from <a href="http://www.americanheart.org/presenter.jhtml?identifier=1596" class="external text" title="http://www.americanheart.org/presenter.jhtml?identifier=1596" rel="nofollow">the original</a> on 2009-03-28<span class="printonly">. <a href="http://www.webcitation.org/5fcMx8BUx" class="external free" title="http://www.webcitation.org/5fcMx8BUx" rel="nofollow">http://www.webcitation.org/5fcMx8BUx</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Atrial+Fibrillation+%28for+Professionals%29&amp;rft.atitle=&amp;rft.date=2008-12-04&amp;rft.pub=American+Heart+Association%2C+Inc.&amp;rft_id=http%3A%2F%2Fwww.webcitation.org%2F5fcMx8BUx&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9737513-1"><b><a href="#cite_ref-pmid9737513_1-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBenjamin_EJ.2C_Wolf_PA.2C_D.27Agostino_RB.2C_Silbershatz_H.2C_Kannel_WB.2C_Levy_D1998">Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D (1998). "Impact of atrial fibrillation on the risk of death: the Framingham Heart Study". <i>Circulation</i> <b>98</b> (10): 946–52. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9737513" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9737513">PMID 9737513</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Impact+of+atrial+fibrillation+on+the+risk+of+death%3A+the+Framingham+Heart+Study&amp;rft.jtitle=Circulation&amp;rft.aulast=Benjamin+EJ%2C+Wolf+PA%2C+D%27Agostino+RB%2C+Silbershatz+H%2C+Kannel+WB%2C+Levy+D&amp;rft.au=Benjamin+EJ%2C+Wolf+PA%2C+D%27Agostino+RB%2C+Silbershatz+H%2C+Kannel+WB%2C+Levy+D&amp;rft.date=1998&amp;rft.volume=98&amp;rft.issue=10&amp;rft.pages=946%E2%80%9352&amp;rft_id=info:pmid/9737513&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWattigney_WA.2C_Mensah_GA.2C_Croft_JB2002">Wattigney WA, Mensah GA, Croft JB (2002). "Increased atrial fibrillation mortality: United States, 1980-1998". <i>Am. J. Epidemiol.</i> <b>155</b> (9): 819–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Faje%2F155.9.819" class="external text" title="http://dx.doi.org/10.1093%2Faje%2F155.9.819" rel="nofollow">10.1093/aje/155.9.819</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11978585" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11978585">PMID 11978585</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Increased+atrial+fibrillation+mortality%3A+United+States%2C+1980-1998&amp;rft.jtitle=Am.+J.+Epidemiol.&amp;rft.aulast=Wattigney+WA%2C+Mensah+GA%2C+Croft+JB&amp;rft.au=Wattigney+WA%2C+Mensah+GA%2C+Croft+JB&amp;rft.date=2002&amp;rft.volume=155&amp;rft.issue=9&amp;rft.pages=819%E2%80%9326&amp;rft_id=info:doi/10.1093%2Faje%2F155.9.819&amp;rft_id=info:pmid/11978585&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17548732-3">^ <a href="#cite_ref-pmid17548732_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17548732_3-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJahangir_A.2C_Lee_V.2C_Friedman_PA.2C_Trusty_JM.2C_Hodge_DO.2C_Kopecky_SL.2C_Packer_DL.2C_Hammill_SC.2C_Shen_WK.2C_Gersh_BJ2007">Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ (2007). "Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study". <i>Circulation</i> <b>115</b> (24): 3050–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.644484" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.644484" rel="nofollow">10.1161/CIRCULATIONAHA.106.644484</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17548732" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17548732">PMID 17548732</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+progression+and+outcomes+with+aging+in+patients+with+lone+atrial+fibrillation%3A+a+30-year+follow-up+study&amp;rft.jtitle=Circulation&amp;rft.aulast=Jahangir+A%2C+Lee+V%2C+Friedman+PA%2C+Trusty+JM%2C+Hodge+DO%2C+Kopecky+SL%2C+Packer+DL%2C+Hammill+SC%2C+Shen+WK%2C+Gersh+BJ&amp;rft.au=Jahangir+A%2C+Lee+V%2C+Friedman+PA%2C+Trusty+JM%2C+Hodge+DO%2C+Kopecky+SL%2C+Packer+DL%2C+Hammill+SC%2C+Shen+WK%2C+Gersh+BJ&amp;rft.date=2007&amp;rft.volume=115&amp;rft.issue=24&amp;rft.pages=3050%E2%80%936&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.106.644484&amp;rft_id=info:pmid/17548732&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wolf1978-4">^ <a href="#cite_ref-Wolf1978_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wolf1978_4-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWolf_PA.2C_Dawber_TR.2C_Thomas_HE.2C_Kannel_WB1978">Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978). "<a href="http://www.neurology.org/cgi/content/abstract/28/10/973" class="external text" title="http://www.neurology.org/cgi/content/abstract/28/10/973" rel="nofollow">Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study</a>". <i>Neurology</i> <b>28</b> (10): 973–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/570666" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/570666">PMID 570666</a><span class="printonly">. <a href="http://www.neurology.org/cgi/content/abstract/28/10/973" class="external free" title="http://www.neurology.org/cgi/content/abstract/28/10/973" rel="nofollow">http://www.neurology.org/cgi/content/abstract/28/10/973</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemiologic+assessment+of+chronic+atrial+fibrillation+and+risk+of+stroke%3A+the+Framingham+study&amp;rft.jtitle=Neurology&amp;rft.aulast=Wolf+PA%2C+Dawber+TR%2C+Thomas+HE%2C+Kannel+WB&amp;rft.au=Wolf+PA%2C+Dawber+TR%2C+Thomas+HE%2C+Kannel+WB&amp;rft.date=1978&amp;rft.volume=28&amp;rft.issue=10&amp;rft.pages=973%E2%80%937&amp;rft_id=info:pmid/570666&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fcontent%2Fabstract%2F28%2F10%2F973&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16908781-5">^ <a href="#cite_ref-pmid16908781_5-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-11" title=""><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-12" title=""><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-13" title=""><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-14" title=""><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-15" title=""><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-16" title=""><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-17" title=""><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-18" title=""><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-19" title=""><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-pmid16908781_5-20" title=""><sup><i><b>u</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFuster_V.2C_Ryd.C3.A9n_LE.2C_Cannom_DS.2C_.27.27et_al.27.272006">Fuster V, Rydén LE, Cannom DS, <i>et al</i> (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". <i>Circulation</i> <b>114</b> (7): e257–354. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.177292" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.177292" rel="nofollow">10.1161/CIRCULATIONAHA.106.177292</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16908781" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16908781">PMID 16908781</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ACC%2FAHA%2FESC+2006+Guidelines+for+the+Management+of+Patients+with+Atrial+Fibrillation%3A+a+report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines+and+the+European+Society+of+Cardiology+Committee+for+Practice+Guidelines+%28Writing+Committee+to+Revise+the+2001+Guidelines+for+the+Management+of+Patients+With+Atrial+Fibrillation%29%3A+developed+in+collaboration+with+the+European+Heart+Rhythm+Association+and+the+Heart+Rhythm+Society&amp;rft.jtitle=Circulation&amp;rft.aulast=Fuster+V%2C+Ryd%C3%A9n+LE%2C+Cannom+DS%2C+%27%27et+al%27%27&amp;rft.au=Fuster+V%2C+Ryd%C3%A9n+LE%2C+Cannom+DS%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=114&amp;rft.issue=7&amp;rft.pages=e257%E2%80%93354&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.106.177292&amp;rft_id=info:pmid/16908781&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLevy_S2000">Levy S (2000). "Classification system of atrial fibrillation". <i>Curr Opin Cardiol</i> <b>15</b> (1): 54–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00001573-200001000-00007" class="external text" title="http://dx.doi.org/10.1097%2F00001573-200001000-00007" rel="nofollow">10.1097/00001573-200001000-00007</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Classification+system+of+atrial+fibrillation&amp;rft.jtitle=Curr+Opin+Cardiol&amp;rft.aulast=Levy+S&amp;rft.au=Levy+S&amp;rft.date=2000&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=54%E2%80%937&amp;rft_id=info:doi/10.1097%2F00001573-200001000-00007&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span> <a href="http://www.ncbi.nlm.nih.gov/pubmed/10666661" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10666661">PMID 10666661</a></li>
<li id="cite_note-pmid17673732-7">^ <a href="#cite_ref-pmid17673732_7-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17673732_7-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFitzmaurice_DA.2C_Hobbs_FD.2C_Jowett_S.2C_.27.27et_al.27.272007">Fitzmaurice DA, Hobbs FD, Jowett S, <i>et al</i> (2007). "Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial". <i>BMJ</i> <b>335</b>: 383. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.39280.660567.55" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.39280.660567.55" rel="nofollow">10.1136/bmj.39280.660567.55</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17673732" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17673732">PMID 17673732</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Screening+versus+routine+practice+in+detection+of+atrial+fibrillation+in+patients+aged+65+or+over%3A+cluster+randomised+controlled+trial&amp;rft.jtitle=BMJ&amp;rft.aulast=Fitzmaurice+DA%2C+Hobbs+FD%2C+Jowett+S%2C+%27%27et+al%27%27&amp;rft.au=Fitzmaurice+DA%2C+Hobbs+FD%2C+Jowett+S%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=335&amp;rft.pages=383&amp;rft_id=info:doi/10.1136%2Fbmj.39280.660567.55&amp;rft_id=info:pmid/17673732&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17604299-8"><b><a href="#cite_ref-pmid17604299_8-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMant_J.2C_Fitzmaurice_DA.2C_Hobbs_FD.2C_.27.27et_al.27.272007">Mant J, Fitzmaurice DA, Hobbs FD, <i>et al</i> (2007). "Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial". <i>BMJ</i> <b>335</b>: 380. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.39227.551713.AE" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.39227.551713.AE" rel="nofollow">10.1136/bmj.39227.551713.AE</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17604299" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17604299">PMID 17604299</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Accuracy+of+diagnosing+atrial+fibrillation+on+electrocardiogram+by+primary+care+practitioners+and+interpretative+diagnostic+software%3A+analysis+of+data+from+screening+for+atrial+fibrillation+in+the+elderly+%28SAFE%29+trial&amp;rft.jtitle=BMJ&amp;rft.aulast=Mant+J%2C+Fitzmaurice+DA%2C+Hobbs+FD%2C+%27%27et+al%27%27&amp;rft.au=Mant+J%2C+Fitzmaurice+DA%2C+Hobbs+FD%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=335&amp;rft.pages=380&amp;rft_id=info:doi/10.1136%2Fbmj.39227.551713.AE&amp;rft_id=info:pmid/17604299&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConen_D.2C_Tedrow_UB.2C_Cook_NR.2C_Moorthy_MV.2C_Buring_JE.2C_Albert_CM2008">Conen D, Tedrow UB, Cook NR, Moorthy MV, Buring JE, Albert CM (December 2008). "<a href="http://jama.ama-assn.org/cgi/content/full/300/21/2489" class="external text" title="http://jama.ama-assn.org/cgi/content/full/300/21/2489" rel="nofollow">Alcohol consumption and risk of incident atrial fibrillation in women</a>". <i>JAMA</i> <b>300</b> (21): 2489–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.2008.755" class="external text" title="http://dx.doi.org/10.1001%2Fjama.2008.755" rel="nofollow">10.1001/jama.2008.755</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19050192" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/19050192">PMID 19050192</a><span class="printonly">. <a href="http://jama.ama-assn.org/cgi/content/full/300/21/2489" class="external free" title="http://jama.ama-assn.org/cgi/content/full/300/21/2489" rel="nofollow">http://jama.ama-assn.org/cgi/content/full/300/21/2489</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Alcohol+consumption+and+risk+of+incident+atrial+fibrillation+in+women&amp;rft.jtitle=JAMA&amp;rft.aulast=Conen+D%2C+Tedrow+UB%2C+Cook+NR%2C+Moorthy+MV%2C+Buring+JE%2C+Albert+CM&amp;rft.au=Conen+D%2C+Tedrow+UB%2C+Cook+NR%2C+Moorthy+MV%2C+Buring+JE%2C+Albert+CM&amp;rft.date=December+2008&amp;rft.volume=300&amp;rft.issue=21&amp;rft.pages=2489%E2%80%9396&amp;rft_id=info:doi/10.1001%2Fjama.2008.755&amp;rft_id=info:pmid/19050192&amp;rft_id=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F300%2F21%2F2489&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSweeney_MO.2C_Bank_AJ.2C_Nsah_E.2C_.27.27et_al.27.272007">Sweeney MO, Bank AJ, Nsah E, <i>et al</i> (2007). "Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease". <i>N. Engl. J. Med.</i> <b>357</b> (10): 1000–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa071880" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa071880" rel="nofollow">10.1056/NEJMoa071880</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17804844" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17804844">PMID 17804844</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Minimizing+ventricular+pacing+to+reduce+atrial+fibrillation+in+sinus-node+disease&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Sweeney+MO%2C+Bank+AJ%2C+Nsah+E%2C+%27%27et+al%27%27&amp;rft.au=Sweeney+MO%2C+Bank+AJ%2C+Nsah+E%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=357&amp;rft.issue=10&amp;rft.pages=1000%E2%80%938&amp;rft_id=info:doi/10.1056%2FNEJMoa071880&amp;rft_id=info:pmid/17804844&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15199036-11"><b><a href="#cite_ref-pmid15199036_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFox_CS.2C_Parise_H.2C_D.27Agostino_RB.2C_.27.27et_al.27.272004">Fox CS, Parise H, D'Agostino RB, <i>et al</i> (2004). "Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring". <i>JAMA</i> <b>291</b> (23): 2851–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.291.23.2851" class="external text" title="http://dx.doi.org/10.1001%2Fjama.291.23.2851" rel="nofollow">10.1001/jama.291.23.2851</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15199036" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15199036">PMID 15199036</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Parental+atrial+fibrillation+as+a+risk+factor+for+atrial+fibrillation+in+offspring&amp;rft.jtitle=JAMA&amp;rft.aulast=Fox+CS%2C+Parise+H%2C+D%27Agostino+RB%2C+%27%27et+al%27%27&amp;rft.au=Fox+CS%2C+Parise+H%2C+D%27Agostino+RB%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.volume=291&amp;rft.issue=23&amp;rft.pages=2851%E2%80%935&amp;rft_id=info:doi/10.1001%2Fjama.291.23.2851&amp;rft_id=info:pmid/15199036&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16790707-12"><b><a href="#cite_ref-pmid16790707_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSaffitz_JE2006">Saffitz JE (2006). "Connexins, conduction, and atrial fibrillation". <i>N. Engl. J. Med.</i> <b>354</b> (25): 2712–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMe068088" class="external text" title="http://dx.doi.org/10.1056%2FNEJMe068088" rel="nofollow">10.1056/NEJMe068088</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16790707" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16790707">PMID 16790707</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Connexins%2C+conduction%2C+and+atrial+fibrillation&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Saffitz+JE&amp;rft.au=Saffitz+JE&amp;rft.date=2006&amp;rft.volume=354&amp;rft.issue=25&amp;rft.pages=2712%E2%80%934&amp;rft_id=info:doi/10.1056%2FNEJMe068088&amp;rft_id=info:pmid/16790707&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8941126-13"><b><a href="#cite_ref-pmid8941126_13-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFElvan_A.2C_Wylie_K.2C_Zipes_D1996">Elvan A, Wylie K, Zipes D (1996). "<a href="http://www.circ.ahajournals.org/cgi/content/abstract/94/11/2953" class="external text" title="http://www.circ.ahajournals.org/cgi/content/abstract/94/11/2953" rel="nofollow">Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling</a>". <i>Circulation</i> <b>94</b> (11): 2953–60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8941126" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8941126">PMID 8941126</a><span class="printonly">. <a href="http://www.circ.ahajournals.org/cgi/content/abstract/94/11/2953" class="external free" title="http://www.circ.ahajournals.org/cgi/content/abstract/94/11/2953" rel="nofollow">http://www.circ.ahajournals.org/cgi/content/abstract/94/11/2953</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pacing-induced+chronic+atrial+fibrillation+impairs+sinus+node+function+in+dogs.+Electrophysiological+remodeling&amp;rft.jtitle=Circulation&amp;rft.aulast=Elvan+A%2C+Wylie+K%2C+Zipes+D&amp;rft.au=Elvan+A%2C+Wylie+K%2C+Zipes+D&amp;rft.date=1996&amp;rft.volume=94&amp;rft.issue=11&amp;rft.pages=2953%E2%80%9360&amp;rft_id=info:pmid/8941126&amp;rft_id=http%3A%2F%2Fwww.circ.ahajournals.org%2Fcgi%2Fcontent%2Fabstract%2F94%2F11%2F2953&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11469431-14"><b><a href="#cite_ref-pmid11469431_14-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFManios_EG.2C_Kanoupakis_EM.2C_Mavrakis_HE.2C_Kallergis_EM.2C_Dermitzaki_DN.2C_Vardas_PE2001">Manios EG, Kanoupakis EM, Mavrakis HE, Kallergis EM, Dermitzaki DN, Vardas PE (2001). "Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence?". <i>Journal of Cardiovascular Electrophysiology</i> <b>12</b> (7): 800–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1540-8167.2001.00800.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1540-8167.2001.00800.x" rel="nofollow">10.1046/j.1540-8167.2001.00800.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11469431" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11469431">PMID 11469431</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sinus+pacemaker+function+after+cardioversion+of+chronic+atrial+fibrillation%3A+is+sinus+node+remodeling+related+with+recurrence%3F&amp;rft.jtitle=Journal+of+Cardiovascular+Electrophysiology&amp;rft.aulast=Manios+EG%2C+Kanoupakis+EM%2C+Mavrakis+HE%2C+Kallergis+EM%2C+Dermitzaki+DN%2C+Vardas+PE&amp;rft.au=Manios+EG%2C+Kanoupakis+EM%2C+Mavrakis+HE%2C+Kallergis+EM%2C+Dermitzaki+DN%2C+Vardas+PE&amp;rft.date=2001&amp;rft.volume=12&amp;rft.issue=7&amp;rft.pages=800%E2%80%936&amp;rft_id=info:doi/10.1046%2Fj.1540-8167.2001.00800.x&amp;rft_id=info:pmid/11469431&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAl-SaadyO._A._Abel.2C_A._J._Camm1999">Al-Saady, N. M.; O. A. Abel, A. J. Camm (1999). "<a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1760793&amp;blobtype=pdf" class="external text" title="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1760793&amp;blobtype=pdf" rel="nofollow">Left atrial appendage: structure, function, and role in thromboembolism</a>". <i>Heart</i> <b>82</b> (5): 547-55. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1760793" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1760793">PMID 1760793</a><span class="printonly">. <a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1760793&amp;blobtype=pdf" class="external free" title="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1760793&amp;blobtype=pdf" rel="nofollow">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1760793&amp;blobtype=pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Left+atrial+appendage%3A+structure%2C+function%2C+and+role+in+thromboembolism&amp;rft.jtitle=Heart&amp;rft.aulast=Al-Saady&amp;rft.aufirst=N.+M.&amp;rft.au=Al-Saady%2C+N.+M.&amp;rft.au=O.+A.+Abel%2C+A.+J.+Camm&amp;rft.date=1999&amp;rft.volume=82&amp;rft.issue=5&amp;rft.pages=547-55&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Fpicrender.fcgi%3Fartid%3D1760793%26blobtype%3Dpdf&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPrystowsky_EN2000">Prystowsky EN (2000). "Management of atrial fibrillation: therapeutic options and clinical decisions". <i>Am J Cardiol</i> <b>85</b> (10A): 3D–11D. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0002-9149%2800%2900908-5" class="external text" title="http://dx.doi.org/10.1016%2FS0002-9149%2800%2900908-5" rel="nofollow">10.1016/S0002-9149(00)00908-5</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Management+of+atrial+fibrillation%3A+therapeutic+options+and+clinical+decisions&amp;rft.jtitle=Am+J+Cardiol&amp;rft.aulast=Prystowsky+EN&amp;rft.au=Prystowsky+EN&amp;rft.date=2000&amp;rft.volume=85&amp;rft.issue=10A&amp;rft.pages=3D%E2%80%9311D&amp;rft_id=info:doi/10.1016%2FS0002-9149%2800%2900908-5&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span> <a href="http://www.ncbi.nlm.nih.gov/pubmed/10822035" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10822035">PMID 10822035</a></li>
<li id="cite_note-pmid17679673-17"><b><a href="#cite_ref-pmid17679673_17-0" title="">^</a></b> <cite style="font-style:normal" class="">"Independent predictors of stroke in patients with atrial fibrillation: a systematic review". <i>Neurology</i> <b>69</b> (6): 546–54. 2007. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1212%2F01.wnl.0000267275.68538.8d" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000267275.68538.8d" rel="nofollow">10.1212/01.wnl.0000267275.68538.8d</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17679673" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17679673">PMID 17679673</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Independent+predictors+of+stroke+in+patients+with+atrial+fibrillation%3A+a+systematic+review&amp;rft.jtitle=Neurology&amp;rft.date=2007&amp;rft.volume=69&amp;rft.issue=6&amp;rft.pages=546%E2%80%9354&amp;rft_id=info:doi/10.1212%2F01.wnl.0000267275.68538.8d&amp;rft_id=info:pmid/17679673&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid3627174-18"><b><a href="#cite_ref-pmid3627174_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKopecky_SL.2C_Gersh_BJ.2C_McGoon_MD.2C_.27.27et_al.27.271987">Kopecky SL, Gersh BJ, McGoon MD, <i>et al</i> (1987). "<a href="http://content.nejm.org/cgi/content/abstract/317/11/669" class="external text" title="http://content.nejm.org/cgi/content/abstract/317/11/669" rel="nofollow">The natural history of lone atrial fibrillation. A population-based study over three decades</a>". <i>N. Engl. J. Med.</i> <b>317</b> (11): 669–74. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3627174" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3627174">PMID 3627174</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/abstract/317/11/669" class="external free" title="http://content.nejm.org/cgi/content/abstract/317/11/669" rel="nofollow">http://content.nejm.org/cgi/content/abstract/317/11/669</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+natural+history+of+lone+atrial+fibrillation.+A+population-based+study+over+three+decades&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Kopecky+SL%2C+Gersh+BJ%2C+McGoon+MD%2C+%27%27et+al%27%27&amp;rft.au=Kopecky+SL%2C+Gersh+BJ%2C+McGoon+MD%2C+%27%27et+al%27%27&amp;rft.date=1987&amp;rft.volume=317&amp;rft.issue=11&amp;rft.pages=669%E2%80%9374&amp;rft_id=info:pmid/3627174&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F317%2F11%2F669&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-nice-19">^ <a href="#cite_ref-nice_19-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nice_19-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFNational_Institute_for_Health_and_Clinical_Excellence2006">National Institute for Health and Clinical Excellence (June 2006). <a href="http://guidance.nice.org.uk/CG36" class="external text" title="http://guidance.nice.org.uk/CG36" rel="nofollow">"Clinical Guideline 36 - Atrial fibrillation"</a><span class="printonly">. <a href="http://guidance.nice.org.uk/CG36" class="external free" title="http://guidance.nice.org.uk/CG36" rel="nofollow">http://guidance.nice.org.uk/CG36</a></span><span class="reference-accessdate">. Retrieved on 2007-08-15</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Clinical+Guideline+36+-+Atrial+fibrillation&amp;rft.atitle=&amp;rft.aulast=National+Institute+for+Health+and+Clinical+Excellence&amp;rft.au=National+Institute+for+Health+and+Clinical+Excellence&amp;rft.date=June+2006&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG36&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10356104-20"><b><a href="#cite_ref-pmid10356104_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHart_RG.2C_Pearce_LA.2C_McBride_R.2C_Rothbart_RM.2C_Asinger_RW1999">Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW (1999). "Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators". <i>Stroke</i> <b>30</b> (6): 1223–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10356104" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10356104">PMID 10356104</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Factors+associated+with+ischemic+stroke+during+aspirin+therapy+in+atrial+fibrillation%3A+analysis+of+2012+participants+in+the+SPAF+I-III+clinical+trials.+The+Stroke+Prevention+in+Atrial+Fibrillation+%28SPAF%29+Investigators&amp;rft.jtitle=Stroke&amp;rft.aulast=Hart+RG%2C+Pearce+LA%2C+McBride+R%2C+Rothbart+RM%2C+Asinger+RW&amp;rft.au=Hart+RG%2C+Pearce+LA%2C+McBride+R%2C+Rothbart+RM%2C+Asinger+RW&amp;rft.date=1999&amp;rft.volume=30&amp;rft.issue=6&amp;rft.pages=1223%E2%80%939&amp;rft_id=info:pmid/10356104&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12941677-21"><b><a href="#cite_ref-pmid12941677_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWang_TJ.2C_Massaro_JM.2C_Levy_D.2C_.27.27et_al.27.272003">Wang TJ, Massaro JM, Levy D, <i>et al</i> (2003). "A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study". <i>JAMA</i> <b>290</b> (8): 1049–56. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.290.8.1049" class="external text" title="http://dx.doi.org/10.1001%2Fjama.290.8.1049" rel="nofollow">10.1001/jama.290.8.1049</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12941677" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12941677">PMID 12941677</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+risk+score+for+predicting+stroke+or+death+in+individuals+with+new-onset+atrial+fibrillation+in+the+community%3A+the+Framingham+Heart+Study&amp;rft.jtitle=JAMA&amp;rft.aulast=Wang+TJ%2C+Massaro+JM%2C+Levy+D%2C+%27%27et+al%27%27&amp;rft.au=Wang+TJ%2C+Massaro+JM%2C+Levy+D%2C+%27%27et+al%27%27&amp;rft.date=2003&amp;rft.volume=290&amp;rft.issue=8&amp;rft.pages=1049%E2%80%9356&amp;rft_id=info:doi/10.1001%2Fjama.290.8.1049&amp;rft_id=info:pmid/12941677&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17673721-22"><b><a href="#cite_ref-pmid17673721_22-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBaruch_L.2C_Gage_BF.2C_Horrow_J.2C_.27.27et_al.27.272007">Baruch L, Gage BF, Horrow J, <i>et al</i> (2007). "Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?". <i>Stroke</i> <b>38</b> (9): 2459–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FSTROKEAHA.106.477133" class="external text" title="http://dx.doi.org/10.1161%2FSTROKEAHA.106.477133" rel="nofollow">10.1161/STROKEAHA.106.477133</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17673721" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17673721">PMID 17673721</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Can+patients+at+elevated+risk+of+stroke+treated+with+anticoagulants+be+further+risk+stratified%3F&amp;rft.jtitle=Stroke&amp;rft.aulast=Baruch+L%2C+Gage+BF%2C+Horrow+J%2C+%27%27et+al%27%27&amp;rft.au=Baruch+L%2C+Gage+BF%2C+Horrow+J%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=38&amp;rft.issue=9&amp;rft.pages=2459%E2%80%9363&amp;rft_id=info:doi/10.1161%2FSTROKEAHA.106.477133&amp;rft_id=info:pmid/17673721&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_Walraven_C.2C_Hart_RG.2C_Singer_DE.2C_.27.27et_al..27.272002">van Walraven C, Hart RG, Singer DE, <i>et al.</i> (2002). "Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis". <i>JAMA</i> <b>288</b> (19): 2441–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.288.19.2441" class="external text" title="http://dx.doi.org/10.1001%2Fjama.288.19.2441" rel="nofollow">10.1001/jama.288.19.2441</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12435257" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12435257">PMID 12435257</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oral+anticoagulants+vs+aspirin+in+nonvalvular+atrial+fibrillation%3A+an+individual+patient+meta-analysis&amp;rft.jtitle=JAMA&amp;rft.aulast=van+Walraven+C%2C+Hart+RG%2C+Singer+DE%2C+%27%27et+al.%27%27&amp;rft.au=van+Walraven+C%2C+Hart+RG%2C+Singer+DE%2C+%27%27et+al.%27%27&amp;rft.date=2002&amp;rft.volume=288&amp;rft.issue=19&amp;rft.pages=2441%26ndash%3B48&amp;rft_id=info:doi/10.1001%2Fjama.288.19.2441&amp;rft_id=info:pmid/12435257&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGage_BF.2C_Cardinalli_AB.2C_Owens_D.1998">Gage BF, Cardinalli AB, Owens D. (1998). "<a href="http://stroke.ahajournals.org/cgi/content/abstract/29/6/1083" class="external text" title="http://stroke.ahajournals.org/cgi/content/abstract/29/6/1083" rel="nofollow">Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation</a>". <i>Stroke</i> <b>29</b>: 1083–91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9626276" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9626276">PMID 9626276</a><span class="printonly">. <a href="http://stroke.ahajournals.org/cgi/content/abstract/29/6/1083" class="external free" title="http://stroke.ahajournals.org/cgi/content/abstract/29/6/1083" rel="nofollow">http://stroke.ahajournals.org/cgi/content/abstract/29/6/1083</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cost-effectiveness+of+preference-based+antithrombotic+therapy+for+patients+with+nonvalvular+atrial+fibrillation&amp;rft.jtitle=Stroke&amp;rft.aulast=Gage+BF%2C+Cardinalli+AB%2C+Owens+D.&amp;rft.au=Gage+BF%2C+Cardinalli+AB%2C+Owens+D.&amp;rft.date=1998&amp;rft.volume=29&amp;rft.pages=1083%26ndash%3B91&amp;rft_id=info:pmid/9626276&amp;rft_id=http%3A%2F%2Fstroke.ahajournals.org%2Fcgi%2Fcontent%2Fabstract%2F29%2F6%2F1083&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17204681-25"><b><a href="#cite_ref-pmid17204681_25-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPaciaroni_M.2C_Agnelli_G.2C_Micheli_S.2C_Caso_V2007">Paciaroni M, Agnelli G, Micheli S, Caso V (2007). "Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials". <i>Stroke</i> <b>38</b> (2): 423–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2F01.STR.0000254600.92975.1f" class="external text" title="http://dx.doi.org/10.1161%2F01.STR.0000254600.92975.1f" rel="nofollow">10.1161/01.STR.0000254600.92975.1f</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17204681" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17204681">PMID 17204681</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+anticoagulant+treatment+in+acute+cardioembolic+stroke%3A+a+meta-analysis+of+randomized+controlled+trials&amp;rft.jtitle=Stroke&amp;rft.aulast=Paciaroni+M%2C+Agnelli+G%2C+Micheli+S%2C+Caso+V&amp;rft.au=Paciaroni+M%2C+Agnelli+G%2C+Micheli+S%2C+Caso+V&amp;rft.date=2007&amp;rft.volume=38&amp;rft.issue=2&amp;rft.pages=423%E2%80%9330&amp;rft_id=info:doi/10.1161%2F01.STR.0000254600.92975.1f&amp;rft_id=info:pmid/17204681&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span> <a href="http://www.acpjc.org/Content/147/1/issue/ACPJC-2007-147-1-017.htm" class="external text" title="http://www.acpjc.org/Content/147/1/issue/ACPJC-2007-147-1-017.htm" rel="nofollow">ACP JC synopsis</a></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAnsell_J.2C_Hirsh_J.2C_Poller_L.2C_Bussey_H.2C_Jacobson_A.2C_Hylek_E2004">Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004). "The Pharmacology and Management of the Vitamin K Antagonists". <i>Chest</i> <b>126</b>: 204S–233S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1378%2Fchest.126.3_suppl.204S" class="external text" title="http://dx.doi.org/10.1378%2Fchest.126.3_suppl.204S" rel="nofollow">10.1378/chest.126.3_suppl.204S</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15383473" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15383473">PMID 15383473</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Pharmacology+and+Management+of+the+Vitamin+K+Antagonists&amp;rft.jtitle=Chest&amp;rft.aulast=Ansell+J%2C+Hirsh+J%2C+Poller+L%2C+Bussey+H%2C+Jacobson+A%2C+Hylek+E&amp;rft.au=Ansell+J%2C+Hirsh+J%2C+Poller+L%2C+Bussey+H%2C+Jacobson+A%2C+Hylek+E&amp;rft.date=2004&amp;rft.volume=126&amp;rft.pages=204S%E2%80%93233S&amp;rft_id=info:doi/10.1378%2Fchest.126.3_suppl.204S&amp;rft_id=info:pmid/15383473&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZeuthen_EL.2C_Lassen_JF.2C_Husted_SE2003">Zeuthen EL, Lassen JF, Husted SE (2003). "Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?". <i>Thrombosis Research</i> <b>109</b> (5-6): 241–246. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.physletb.2003.10.071" class="external text" title="http://dx.doi.org/10.1016%2Fj.physletb.2003.10.071" rel="nofollow">10.1016/j.physletb.2003.10.071</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Is+there+a+hypercoagulable+phase+during+initiation+of+antithrombotic+therapy+with+oral+anticoagulants+in+patients+with+atrial+fibrillation%3F&amp;rft.jtitle=Thrombosis+Research&amp;rft.aulast=Zeuthen+EL%2C+Lassen+JF%2C+Husted+SE&amp;rft.au=Zeuthen+EL%2C+Lassen+JF%2C+Husted+SE&amp;rft.date=2003&amp;rft.volume=109&amp;rft.issue=5-6&amp;rft.pages=241%E2%80%93246&amp;rft_id=info:doi/10.1016%2Fj.physletb.2003.10.071&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17577005-28"><b><a href="#cite_ref-pmid17577005_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHart_RG.2C_Pearce_LA.2C_Aguilar_MI2007">Hart RG, Pearce LA, Aguilar MI (2007). "Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation". <i>Ann Intern Med</i> <b>146</b> (12): 857–67. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17577005" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17577005">PMID 17577005</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Meta-analysis%3A+antithrombotic+therapy+to+prevent+stroke+in+patients+who+have+nonvalvular+atrial+fibrillation&amp;rft.jtitle=Ann+Intern+Med&amp;rft.aulast=Hart+RG%2C+Pearce+LA%2C+Aguilar+MI&amp;rft.au=Hart+RG%2C+Pearce+LA%2C+Aguilar+MI&amp;rft.date=2007&amp;rft.volume=146&amp;rft.issue=12&amp;rft.pages=857%E2%80%9367&amp;rft_id=info:pmid/17577005&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17636831-29"><b><a href="#cite_ref-pmid17636831_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAguilar_M.2C_Hart_R.2C_Pearce_L2007">Aguilar M, Hart R, Pearce L (2007). "Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks". <i>Cochrane Database Syst Rev</i> <b>3</b>: CD006186. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD006186.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD006186.pub2" rel="nofollow">10.1002/14651858.CD006186.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17636831" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17636831">PMID 17636831</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oral+anticoagulants+versus+antiplatelet+therapy+for+preventing+stroke+in+patients+with+non-valvular+atrial+fibrillation+and+no+history+of+stroke+or+transient+ischemic+attacks&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Aguilar+M%2C+Hart+R%2C+Pearce+L&amp;rft.au=Aguilar+M%2C+Hart+R%2C+Pearce+L&amp;rft.date=2007&amp;rft.volume=3&amp;rft.pages=CD006186&amp;rft_id=info:doi/10.1002%2F14651858.CD006186.pub2&amp;rft_id=info:pmid/17636831&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16765759-30"><b><a href="#cite_ref-pmid16765759_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConnolly_S.2C_Pogue_J.2C_Hart_R.2C_.27.27et_al.27.272006">Connolly S, Pogue J, Hart R, <i>et al</i> (2006). "Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial". <i>Lancet</i> <b>367</b> (9526): 1903–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2806%2968845-4" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2806%2968845-4" rel="nofollow">10.1016/S0140-6736(06)68845-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16765759" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16765759">PMID 16765759</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clopidogrel+plus+aspirin+versus+oral+anticoagulation+for+atrial+fibrillation+in+the+Atrial+fibrillation+Clopidogrel+Trial+with+Irbesartan+for+prevention+of+Vascular+Events+%28ACTIVE+W%29%3A+a+randomised+controlled+trial&amp;rft.jtitle=Lancet&amp;rft.aulast=Connolly+S%2C+Pogue+J%2C+Hart+R%2C+%27%27et+al%27%27&amp;rft.au=Connolly+S%2C+Pogue+J%2C+Hart+R%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=367&amp;rft.issue=9526&amp;rft.pages=1903%E2%80%9312&amp;rft_id=info:doi/10.1016%2FS0140-6736%2806%2968845-4&amp;rft_id=info:pmid/16765759&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://www.thelancet.com/journals/lancet/article/PIIS0140673696034873/abstract" class="external text" title="http://www.thelancet.com/journals/lancet/article/PIIS0140673696034873/abstract" rel="nofollow">Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial</a>". <i>Lancet</i> <b>348</b> (9028): 633–638. 1996. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2896%2903487-3" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2896%2903487-3" rel="nofollow">10.1016/S0140-6736(96)03487-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8782752" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8782752">PMID 8782752</a><span class="printonly">. <a href="http://www.thelancet.com/journals/lancet/article/PIIS0140673696034873/abstract" class="external free" title="http://www.thelancet.com/journals/lancet/article/PIIS0140673696034873/abstract" rel="nofollow">http://www.thelancet.com/journals/lancet/article/PIIS0140673696034873/abstract</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Adjusted-dose+warfarin+versus+low-intensity%2C+fixed-dose+warfarin+plus+aspirin+for+high-risk+patients+with+atrial+fibrillation%3A+Stroke+Prevention+in+Atrial+Fibrillation+III+randomised+clinical+trial&amp;rft.jtitle=Lancet&amp;rft.date=1996&amp;rft.volume=348&amp;rft.issue=9028&amp;rft.pages=633%E2%80%93638&amp;rft_id=info:doi/10.1016%2FS0140-6736%2896%2903487-3&amp;rft_id=info:pmid/8782752&amp;rft_id=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140673696034873%2Fabstract&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17515465-32"><b><a href="#cite_ref-pmid17515465_32-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHylek_EM.2C_Evans-Molina_C.2C_Shea_C.2C_Henault_LE.2C_Regan_S2007">Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007). "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation". <i>Circulation</i> <b>115</b> (21): 2689–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.653048" class="external text" title="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.653048" rel="nofollow">10.1161/CIRCULATIONAHA.106.653048</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17515465" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17515465">PMID 17515465</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Major+hemorrhage+and+tolerability+of+warfarin+in+the+first+year+of+therapy+among+elderly+patients+with+atrial+fibrillation&amp;rft.jtitle=Circulation&amp;rft.aulast=Hylek+EM%2C+Evans-Molina+C%2C+Shea+C%2C+Henault+LE%2C+Regan+S&amp;rft.au=Hylek+EM%2C+Evans-Molina+C%2C+Shea+C%2C+Henault+LE%2C+Regan+S&amp;rft.date=2007&amp;rft.volume=115&amp;rft.issue=21&amp;rft.pages=2689%E2%80%9396&amp;rft_id=info:doi/10.1161%2FCIRCULATIONAHA.106.653048&amp;rft_id=info:pmid/17515465&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmidpendingMant-33"><b><a href="#cite_ref-pmidpendingMant_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMant_J_et_al2007">Mant J et al (2007). "Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial". <i>Lancet</i> <b>370</b>: 493–503. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961233-1" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961233-1" rel="nofollow">10.1016/S0140-6736(07)61233-1</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Warfarin+versus+aspirin+for+stroke+prevention+in+an+elderly+community+population+with+atrial+fibrillation+%28the+Birmingham+Atrial+Fibrillation+Treatment+of+the+Aged+Study%2C+BAFTA%29%3A+a+randomised+controlled+trial&amp;rft.jtitle=Lancet&amp;rft.aulast=Mant+J+et+al&amp;rft.au=Mant+J+et+al&amp;rft.date=2007&amp;rft.volume=370&amp;rft.pages=493%E2%80%93503&amp;rft_id=info:doi/10.1016%2FS0140-6736%2807%2961233-1&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSingh_BN.2C_Connolly_SJ.2C_Crijns_HJ.2C_.27.27et_al.27.272007">Singh BN, Connolly SJ, Crijns HJ, <i>et al</i> (2007). "Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter". <i>N. Engl. J. Med.</i> <b>357</b> (10): 987–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa054686" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa054686" rel="nofollow">10.1056/NEJMoa054686</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17804843" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17804843">PMID 17804843</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dronedarone+for+maintenance+of+sinus+rhythm+in+atrial+fibrillation+or+flutter&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Singh+BN%2C+Connolly+SJ%2C+Crijns+HJ%2C+%27%27et+al%27%27&amp;rft.au=Singh+BN%2C+Connolly+SJ%2C+Crijns+HJ%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=357&amp;rft.issue=10&amp;rft.pages=987%E2%80%9399&amp;rft_id=info:doi/10.1056%2FNEJMoa054686&amp;rft_id=info:pmid/17804843&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12466506-35">^ <a href="#cite_ref-pmid12466506_35-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12466506_35-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWyse_DG.2C_Waldo_AL.2C_DiMarco_JP.2C_Domanski_MJ.2C_Rosenberg_Y.2C_Schron_EB.2C_Kellen_JC.2C_Greene_HL.2C_Mickel_MC.2C_Dalquist_JE.2C_Corley_SD2002">Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002). "A comparison of rate control and rhythm control in patients with atrial fibrillation". <i>N Engl J Med</i> <b>347</b> (23): 1825–33.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+rate+control+and+rhythm+control+in+patients+with+atrial+fibrillation&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Wyse+DG%2C+Waldo+AL%2C+DiMarco+JP%2C+Domanski+MJ%2C+Rosenberg+Y%2C+Schron+EB%2C+Kellen+JC%2C+Greene+HL%2C+Mickel+MC%2C+Dalquist+JE%2C+Corley+SD&amp;rft.au=Wyse+DG%2C+Waldo+AL%2C+DiMarco+JP%2C+Domanski+MJ%2C+Rosenberg+Y%2C+Schron+EB%2C+Kellen+JC%2C+Greene+HL%2C+Mickel+MC%2C+Dalquist+JE%2C+Corley+SD&amp;rft.date=2002&amp;rft.volume=347&amp;rft.issue=23&amp;rft.pages=1825%E2%80%9333&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span> <a href="http://www.ncbi.nlm.nih.gov/pubmed/12466506" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12466506">PMID 12466506</a></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThrall_G.2C_Lane_D.2C_Carroll_D.2C_Lip_GY2006">Thrall G, Lane D, Carroll D, Lip GY (2006). "Quality of life in patients with atrial fibrillation: a systematic review". <i>Am. J. Med.</i> <b>119</b> (5): 448.e1–19. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.amjmed.2005.10.057" class="external text" title="http://dx.doi.org/10.1016%2Fj.amjmed.2005.10.057" rel="nofollow">10.1016/j.amjmed.2005.10.057</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16651058" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16651058">PMID 16651058</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Quality+of+life+in+patients+with+atrial+fibrillation%3A+a+systematic+review&amp;rft.jtitle=Am.+J.+Med.&amp;rft.aulast=Thrall+G%2C+Lane+D%2C+Carroll+D%2C+Lip+GY&amp;rft.au=Thrall+G%2C+Lane+D%2C+Carroll+D%2C+Lip+GY&amp;rft.date=2006&amp;rft.volume=119&amp;rft.issue=5&amp;rft.pages=448.e1%E2%80%9319&amp;rft_id=info:doi/10.1016%2Fj.amjmed.2005.10.057&amp;rft_id=info:pmid/16651058&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRoy_D.2C_Talajic_M.2C_Nattel_S.2C_.27.27et_al.27.272008">Roy D, Talajic M, Nattel S, <i>et al</i> (June 2008). "Rhythm control versus rate control for atrial fibrillation and heart failure". <i>N Engl J Med</i> <b>358</b> (25): 2667-2677.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rhythm+control+versus+rate+control+for+atrial+fibrillation+and+heart+failure&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Roy+D%2C+Talajic+M%2C+Nattel+S%2C+%27%27et+al%27%27&amp;rft.au=Roy+D%2C+Talajic+M%2C+Nattel+S%2C+%27%27et+al%27%27&amp;rft.date=June+2008&amp;rft.volume=358&amp;rft.issue=25&amp;rft.pages=2667-2677&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOnalan_O.2C_Crystal_E.2C_Daoulah_A.2C_Lau_C.2C_Crystal_A.2C_Lashevsky_I2007">Onalan O, Crystal E, Daoulah A, Lau C, Crystal A, Lashevsky I (2007). "Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation". <i>Am. J. Cardiol.</i> <b>99</b> (12): 1726–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.amjcard.2007.01.057" class="external text" title="http://dx.doi.org/10.1016%2Fj.amjcard.2007.01.057" rel="nofollow">10.1016/j.amjcard.2007.01.057</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17560883" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17560883">PMID 17560883</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Meta-analysis+of+magnesium+therapy+for+the+acute+management+of+rapid+atrial+fibrillation&amp;rft.jtitle=Am.+J.+Cardiol.&amp;rft.aulast=Onalan+O%2C+Crystal+E%2C+Daoulah+A%2C+Lau+C%2C+Crystal+A%2C+Lashevsky+I&amp;rft.au=Onalan+O%2C+Crystal+E%2C+Daoulah+A%2C+Lau+C%2C+Crystal+A%2C+Lashevsky+I&amp;rft.date=2007&amp;rft.volume=99&amp;rft.issue=12&amp;rft.pages=1726%E2%80%9332&amp;rft_id=info:doi/10.1016%2Fj.amjcard.2007.01.057&amp;rft_id=info:pmid/17560883&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <a href="http://www.clevelandclinic.org/heartcenter/pub/atrial_fibrillation/pulmonaryvein_ablation.htm" class="external text" title="http://www.clevelandclinic.org/heartcenter/pub/atrial_fibrillation/pulmonaryvein_ablation.htm" rel="nofollow">The Cleveland Clinic</a></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <a href="http://www.medscape.com/viewarticle/532503_2" class="external text" title="http://www.medscape.com/viewarticle/532503_2" rel="nofollow">Medscape</a></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNademanee_K.2C_McKenzie_J.2C_Kosar_E.2C_Schwab_M.2C_Sunsaneewitayakul_B.2C_Vasavakul_T.2C_Khunnawat_C.2C_Ngarmukos_T.2004">Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. (2004). "A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate". <i>J Am Coll Cardiol</i> <b>43</b> (11): 2044–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jacc.2003.12.054" class="external text" title="http://dx.doi.org/10.1016%2Fj.jacc.2003.12.054" rel="nofollow">10.1016/j.jacc.2003.12.054</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15172410" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15172410">PMID 15172410</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+new+approach+for+catheter+ablation+of+atrial+fibrillation%3A+mapping+of+the+electrophysiologic+substrate&amp;rft.jtitle=J+Am+Coll+Cardiol&amp;rft.aulast=Nademanee+K%2C+McKenzie+J%2C+Kosar+E%2C+Schwab+M%2C+Sunsaneewitayakul+B%2C+Vasavakul+T%2C+Khunnawat+C%2C+Ngarmukos+T.&amp;rft.au=Nademanee+K%2C+McKenzie+J%2C+Kosar+E%2C+Schwab+M%2C+Sunsaneewitayakul+B%2C+Vasavakul+T%2C+Khunnawat+C%2C+Ngarmukos+T.&amp;rft.date=2004&amp;rft.volume=43&amp;rft.issue=11&amp;rft.pages=2044%E2%80%9353&amp;rft_id=info:doi/10.1016%2Fj.jacc.2003.12.054&amp;rft_id=info:pmid/15172410&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCappato_R.2C_Calkins_H.2C_Chen_SA.2C_Davies_W.2C_Iesaka_Y.2C_Kalman_J.2C_Kim_YH.2C_Klein_G.2C_Packer_D.2C_Skanes_A.2005">Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A. (2005). "Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation". <i>Circulation</i> <b>111</b>: 1100–1105. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2F01.CIR.0000157153.30978.67" class="external text" title="http://dx.doi.org/10.1161%2F01.CIR.0000157153.30978.67" rel="nofollow">10.1161/01.CIR.0000157153.30978.67</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15723973" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15723973">PMID 15723973</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Worldwide+survey+on+the+methods%2C+efficacy%2C+and+safety+of+catheter+ablation+for+human+atrial+fibrillation&amp;rft.jtitle=Circulation&amp;rft.aulast=Cappato+R%2C+Calkins+H%2C+Chen+SA%2C+Davies+W%2C+Iesaka+Y%2C+Kalman+J%2C+Kim+YH%2C+Klein+G%2C+Packer+D%2C+Skanes+A.&amp;rft.au=Cappato+R%2C+Calkins+H%2C+Chen+SA%2C+Davies+W%2C+Iesaka+Y%2C+Kalman+J%2C+Kim+YH%2C+Klein+G%2C+Packer+D%2C+Skanes+A.&amp;rft.date=2005&amp;rft.volume=111&amp;rft.pages=1100%E2%80%931105&amp;rft_id=info:doi/10.1161%2F01.CIR.0000157153.30978.67&amp;rft_id=info:pmid/15723973&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCalkins_H.2C_Brugada_J.2C_Packer_DL.2C_Cappato_R.2C_Chen_SA.2C_Crijns_HJ.2C_Damiano_RJ_Jr.2C_Davies_DW.2C_Haines_DE.2C_Haissaguerre_M.2C_Iesaka_Y.2C_Jackman_W.2C_Jais_P.2C_Kottkamp_H.2C_Kuck_KH.2C_Lindsay_BD.2C_Marchlinski_FE.2C_McCarthy_PM.2C_Mont_JL.2C_Morady_F.2C_Nademanee_K.2C_Natale_A.2C_Pappone_C.2C_Prystowsky_E.2C_Raviele_A.2C_Ruskin_JN.2C_Shemin_RJ.2007">Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ. (2007). "HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation". <i>Heart Rhythm</i> <b>4</b> (6): 816–61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17556213" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17556213">PMID 17556213</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=HRS%2FEHRA%2FECAS+expert+Consensus+Statement+on+catheter+and+surgical+ablation+of+atrial+fibrillation%3A+recommendations+for+personnel%2C+policy%2C+procedures+and+follow-up.+A+report+of+the+Heart+Rhythm+Society+%28HRS%29+Task+Force+on+catheter+and+surgical+ablation+of+atrial+fibrillation&amp;rft.jtitle=Heart+Rhythm&amp;rft.aulast=Calkins+H%2C+Brugada+J%2C+Packer+DL%2C+Cappato+R%2C+Chen+SA%2C+Crijns+HJ%2C+Damiano+RJ+Jr%2C+Davies+DW%2C+Haines+DE%2C+Haissaguerre+M%2C+Iesaka+Y%2C+Jackman+W%2C+Jais+P%2C+Kottkamp+H%2C+Kuck+KH%2C+Lindsay+BD%2C+Marchlinski+FE%2C+McCarthy+PM%2C+Mont+JL%2C+Morady+F%2C+Nademanee+K%2C+Natale+A%2C+Pappone+C%2C+Prystowsky+E%2C+Raviele+A%2C+Ruskin+JN%2C+Shemin+RJ.&amp;rft.au=Calkins+H%2C+Brugada+J%2C+Packer+DL%2C+Cappato+R%2C+Chen+SA%2C+Crijns+HJ%2C+Damiano+RJ+Jr%2C+Davies+DW%2C+Haines+DE%2C+Haissaguerre+M%2C+Iesaka+Y%2C+Jackman+W%2C+Jais+P%2C+Kottkamp+H%2C+Kuck+KH%2C+Lindsay+BD%2C+Marchlinski+FE%2C+McCarthy+PM%2C+Mont+JL%2C+Morady+F%2C+Nademanee+K%2C+Natale+A%2C+Pappone+C%2C+Prystowsky+E%2C+Raviele+A%2C+Ruskin+JN%2C+Shemin+RJ.&amp;rft.date=2007&amp;rft.volume=4&amp;rft.issue=6&amp;rft.pages=816%E2%80%9361&amp;rft_id=info:pmid/17556213&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCox_JL.2C_Schuessler_RB.2C_Lappas_DG.2C_Boineau_JP1996">Cox JL, Schuessler RB, Lappas DG, Boineau JP (1996). "An 8 1/2-year clinical experience with surgery for atrial fibrillation". <i>Ann. Surg.</i> <b>224</b> (3): 267–73; discussion 273–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00000658-199609000-00003" class="external text" title="http://dx.doi.org/10.1097%2F00000658-199609000-00003" rel="nofollow">10.1097/00000658-199609000-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8813255" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8813255">PMID 8813255</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+8+1%2F2-year+clinical+experience+with+surgery+for+atrial+fibrillation&amp;rft.jtitle=Ann.+Surg.&amp;rft.aulast=Cox+JL%2C+Schuessler+RB%2C+Lappas+DG%2C+Boineau+JP&amp;rft.au=Cox+JL%2C+Schuessler+RB%2C+Lappas+DG%2C+Boineau+JP&amp;rft.date=1996&amp;rft.volume=224&amp;rft.issue=3&amp;rft.pages=267%E2%80%9373%3B+discussion+273%E2%80%935&amp;rft_id=info:doi/10.1097%2F00000658-199609000-00003&amp;rft_id=info:pmid/8813255&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Saltman2003-45"><b><a href="#cite_ref-Saltman2003_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSaltmanLS_Rosenthal.2C_NA_Francalancia.2C_SJ_Lahey2003">Saltman, AE; LS Rosenthal, NA Francalancia, SJ Lahey (2003). "<a href="http://www.bioingenieria.edu.ar/academica/catedras/radiaciones/ablacionendoscopia.pdf" class="external text" title="http://www.bioingenieria.edu.ar/academica/catedras/radiaciones/ablacionendoscopia.pdf" rel="nofollow">A completely endoscopic approach to microwave ablation for atrial fibrillation</a>". <i>The Heart Surgery Forum</i> <b>6</b> (3): E38-41. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12821436" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12821436">PMID 12821436</a><span class="printonly">. <a href="http://www.bioingenieria.edu.ar/academica/catedras/radiaciones/ablacionendoscopia.pdf" class="external free" title="http://www.bioingenieria.edu.ar/academica/catedras/radiaciones/ablacionendoscopia.pdf" rel="nofollow">http://www.bioingenieria.edu.ar/academica/catedras/radiaciones/ablacionendoscopia.pdf</a></span><span class="reference-accessdate">. Retrieved on 2009-02-08</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+completely+endoscopic+approach+to+microwave+ablation+for+atrial+fibrillation&amp;rft.jtitle=The+Heart+Surgery+Forum&amp;rft.aulast=Saltman&amp;rft.aufirst=AE&amp;rft.au=Saltman%2C+AE&amp;rft.au=LS+Rosenthal%2C+NA+Francalancia%2C+SJ+Lahey&amp;rft.date=2003&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=E38-41&amp;rft_id=http%3A%2F%2Fwww.bioingenieria.edu.ar%2Facademica%2Fcatedras%2Fradiaciones%2Fablacionendoscopia.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-rwjHosp-46"><b><a href="#cite_ref-rwjHosp_46-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.rwjuh.edu/medical_services/min_invasive_atrial_fibrillation.html" class="external text" title="http://www.rwjuh.edu/medical_services/min_invasive_atrial_fibrillation.html" rel="nofollow">"Minimally Invasive Atrial Fibrillation Treatment"</a>. Robert Wood Johnson University Hospital. 2008<span class="printonly">. <a href="http://www.rwjuh.edu/medical_services/min_invasive_atrial_fibrillation.html" class="external free" title="http://www.rwjuh.edu/medical_services/min_invasive_atrial_fibrillation.html" rel="nofollow">http://www.rwjuh.edu/medical_services/min_invasive_atrial_fibrillation.html</a></span><span class="reference-accessdate">. Retrieved on 2009-02-08</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Minimally+Invasive+Atrial+Fibrillation+Treatment&amp;rft.atitle=&amp;rft.date=2008&amp;rft.pub=Robert+Wood+Johnson+University+Hospital&amp;rft_id=http%3A%2F%2Fwww.rwjuh.edu%2Fmedical_services%2Fmin_invasive_atrial_fibrillation.html&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-ex-maze-47"><b><a href="#cite_ref-ex-maze_47-0" title="">^</a></b> Kiser AC, Wimmer-Greinecker G, Chitwood WR. Totally extracardiac maze procedure performed on the beating heart. Ann Thorac Surg 2007; 84:1783-85.</li>
<li id="cite_note-pattern-48"><b><a href="#cite_ref-pattern_48-0" title="">^</a></b> Kiser AC, Wimmer-Greinecker G, Kapelak B, Bartus K, Streitman JS, Knaut M, Sadowski J. Achieving Metrics during Beating Heart Ex-Maze Procedures Improves Outcomes. Heart Surgery Forum. 2008; 11:E237-E242.</li>
<li id="cite_note-pattern1-49"><b><a href="#cite_ref-pattern1_49-0" title="">^</a></b> Kiser AC, Nifong LW, Raman J, Kasirajan V, Campbell N, Chitwood, Jr. WR. Evaluation of a Novel Epicardial Atrial Fibrillation Treatment System. Ann Thorac Surg 2008; 85:300-303.</li>
<li id="cite_note-Friberg-2003-50"><b><a href="#cite_ref-Friberg-2003_50-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFriberg_J.2C_Buch_P.2C_Scharling_H.2C_Gadsbphioll_N.2C_Jensen_GB.2003">Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. (2003). "Rising rates of hospital admissions for atrial fibrillation". <i>Epidemiology</i> <b>14</b> (6): 666–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.ede.0000091649.26364.c0" class="external text" title="http://dx.doi.org/10.1097%2F01.ede.0000091649.26364.c0" rel="nofollow">10.1097/01.ede.0000091649.26364.c0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14569181" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14569181">PMID 14569181</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rising+rates+of+hospital+admissions+for+atrial+fibrillation&amp;rft.jtitle=Epidemiology&amp;rft.aulast=Friberg+J%2C+Buch+P%2C+Scharling+H%2C+Gadsbphioll+N%2C+Jensen+GB.&amp;rft.au=Friberg+J%2C+Buch+P%2C+Scharling+H%2C+Gadsbphioll+N%2C+Jensen+GB.&amp;rft.date=2003&amp;rft.volume=14&amp;rft.issue=6&amp;rft.pages=666%E2%80%9372&amp;rft_id=info:doi/10.1097%2F01.ede.0000091649.26364.c0&amp;rft_id=info:pmid/14569181&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGo_AS.2C_Hylek_EM.2C_Phillips_KA.2C_.27.27et_al.27.272001">Go AS, Hylek EM, Phillips KA, <i>et al</i> (2001). "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study". <i>JAMA</i> <b>285</b> (18): 2370–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.285.18.2370" class="external text" title="http://dx.doi.org/10.1001%2Fjama.285.18.2370" rel="nofollow">10.1001/jama.285.18.2370</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11343485" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11343485">PMID 11343485</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+diagnosed+atrial+fibrillation+in+adults%3A+national+implications+for+rhythm+management+and+stroke+prevention%3A+the+AnTicoagulation+and+Risk+Factors+in+Atrial+Fibrillation+%28ATRIA%29+Study&amp;rft.jtitle=JAMA&amp;rft.aulast=Go+AS%2C+Hylek+EM%2C+Phillips+KA%2C+%27%27et+al%27%27&amp;rft.au=Go+AS%2C+Hylek+EM%2C+Phillips+KA%2C+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.volume=285&amp;rft.issue=18&amp;rft.pages=2370%E2%80%935&amp;rft_id=info:doi/10.1001%2Fjama.285.18.2370&amp;rft_id=info:pmid/11343485&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFurberg_CD.2C_Psaty_BM.2C_Manolio_TA.2C_Gardin_JM.2C_Smith_VE.2C_Rautaharju_PM1994">Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM (1994). "Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)". <i>Am. J. Cardiol.</i> <b>74</b> (3): 236–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0002-9149%2894%2990363-8" class="external text" title="http://dx.doi.org/10.1016%2F0002-9149%2894%2990363-8" rel="nofollow">10.1016/0002-9149(94)90363-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8037127" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8037127">PMID 8037127</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+atrial+fibrillation+in+elderly+subjects+%28the+Cardiovascular+Health+Study%29&amp;rft.jtitle=Am.+J.+Cardiol.&amp;rft.aulast=Furberg+CD%2C+Psaty+BM%2C+Manolio+TA%2C+Gardin+JM%2C+Smith+VE%2C+Rautaharju+PM&amp;rft.au=Furberg+CD%2C+Psaty+BM%2C+Manolio+TA%2C+Gardin+JM%2C+Smith+VE%2C+Rautaharju+PM&amp;rft.date=1994&amp;rft.volume=74&amp;rft.issue=3&amp;rft.pages=236%E2%80%9341&amp;rft_id=info:doi/10.1016%2F0002-9149%2894%2990363-8&amp;rft_id=info:pmid/8037127&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGo_AS.2C_Hylek_EM.2C_Phillips_KA.2C_Chang_Y.2C_Henault_LE.2C_Selby_JV.2C_Singer_DE2001">Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001). "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study". <i>JAMA</i> <b>285</b> (18): 2370–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.285.18.2370" class="external text" title="http://dx.doi.org/10.1001%2Fjama.285.18.2370" rel="nofollow">10.1001/jama.285.18.2370</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11343485" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11343485">PMID 11343485</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+diagnosed+atrial+fibrillation+in+adults%3A+national+implications+for+rhythm+management+and+stroke+prevention%3A+the+AnTicoagulation+and+Risk+Factors+in+Atrial+Fibrillation+%28ATRIA%29+Study&amp;rft.jtitle=JAMA&amp;rft.aulast=Go+AS%2C+Hylek+EM%2C+Phillips+KA%2C+Chang+Y%2C+Henault+LE%2C+Selby+JV%2C+Singer+DE&amp;rft.au=Go+AS%2C+Hylek+EM%2C+Phillips+KA%2C+Chang+Y%2C+Henault+LE%2C+Selby+JV%2C+Singer+DE&amp;rft.date=2001&amp;rft.volume=285&amp;rft.issue=18&amp;rft.pages=2370%E2%80%935&amp;rft_id=info:doi/10.1001%2Fjama.285.18.2370&amp;rft_id=info:pmid/11343485&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span> <a href="http://www.ncbi.nlm.nih.gov/pubmed/11343485" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11343485">PMID 11343485</a></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> Vulpian A. (1874). Note sur les effets de la faradisation directe des ventricules du coeur chez le chien. <i>Archives de Physiologie Normale et Pathologique</i> <b>6</b>:975.</li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> McMichael J. (1982). History of atrial fibrillation 1628-1819 Harvey-de Senac-Laennec. <i>Br Heart J</i> <b>48</b>: 193-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7049202" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7049202">PMID 7049202</a>.</li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> Nothnagel H. (1876). Ueber arythmische Herzthatigkeit. <i>Deutsches Archiv fur Klinische Medizin</i> <b>17</b>: 190-220.</li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> MacKenzie J. (1904). The inception of the rhythm of the heart by the ventricle. <i>Br Med J</i> <b>1</b>: 529-36.</li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> Einthoven W. (1906). Le telecardiogramme. <i>Archives Internationales de Physiologie</i> <b>4</b>: 132-64.</li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> Rothberger CJ, Winterberg H. (1909). Vorhofflimmern und Arhythmia perpetua. <i>Wiener Klinische Wochenschrift</i> <b>22</b>: 839-44</li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> Lewis T (1909). Auricular fibrillation: a common clinical condition. <i>Br Med J</i> <b>2</b>: 1528</li>
<li id="cite_note-61"><b><a href="#cite_ref-61" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFlegel_KM1995">Flegel KM (1995). "From delirium cordis to atrial fibrillation: historical development of a disease concept". <i>Ann. Intern. Med.</i> <b>122</b> (11): 867–73. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7741373" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7741373">PMID 7741373</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=From+delirium+cordis+to+atrial+fibrillation%3A+historical+development+of+a+disease+concept&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=Flegel+KM&amp;rft.au=Flegel+KM&amp;rft.date=1995&amp;rft.volume=122&amp;rft.issue=11&amp;rft.pages=867%E2%80%9373&amp;rft_id=info:pmid/7741373&amp;rfr_id=info:sid/en.wikipedia.org:Atrial_fibrillation"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit&amp;section=38" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.americanheart.org/presenter.jhtml?identifier=4451" class="external text" title="http://www.americanheart.org/presenter.jhtml?identifier=4451" rel="nofollow">American Heart Association</a> page on atrial fibrillation</li>
<li><a href="http://www.patient.co.uk/showdoc/23068682/" class="external text" title="http://www.patient.co.uk/showdoc/23068682/" rel="nofollow">Atrial fibrillation</a> at patient.co.uk</li>
<li><a href="http://www.jr2.ox.ac.uk/bandolier/booth/booths/AF.html" class="external text" title="http://www.jr2.ox.ac.uk/bandolier/booth/booths/AF.html" rel="nofollow">Bandolier</a> (evidence-based medicine) resource on atrial fibrillation</li>
<li><a href="https://online.epocrates.com/u/29111/Chronic+atrial+fibrillation" class="external text" title="https://online.epocrates.com/u/29111/Chronic+atrial+fibrillation" rel="nofollow">Atrial fibrillation</a> at <a href="https://online.epocrates.com" class="external text" title="https://online.epocrates.com" rel="nofollow">Epocrates Online</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Heart_diseases" title="Template:Heart diseases"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Heart_diseases" title="Template talk:Heart diseases"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Heart_diseases&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Heart_diseases&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">Cardiovascular disease</a>: <a href="/wiki/Heart_disease" title="Heart disease">heart disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Circulatory_system" title="Circulatory system">Circulatory system</a> <a href="/wiki/Pathology" title="Pathology">pathology</a> (<a href="/wiki/ICD-10_Chapter_IX:_Diseases_of_the_circulatory_system" title="ICD-10 Chapter IX: Diseases of the circulatory system">I00-I52</a>, <a href="/wiki/List_of_ICD-9_codes_390-459:_Diseases_of_the_circulatory_system" title="List of ICD-9 codes 390-459: Diseases of the circulatory system" class="mw-redirect">390-429</a>)</span></th>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Ischaemic_heart_disease" title="Ischaemic heart disease">Ischaemic</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Coronary_disease" title="Coronary disease">CD/CHD</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">CAD</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_thrombosis" title="Coronary thrombosis">Coronary thrombosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_vasospasm" title="Coronary vasospasm">Coronary vasospasm</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Coronary_artery_aneurysm" title="Coronary artery aneurysm">Coronary artery aneurysm</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">Active <a href="/wiki/Ischemia" title="Ischemia">ischemia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Angina_pectoris" title="Angina pectoris">Angina pectoris</a> (<a href="/wiki/Prinzmetal%27s_angina" title="Prinzmetal's angina">Prinzmetal's angina</a>, <a href="/wiki/Stable_angina" title="Stable angina" class="mw-redirect">Stable angina</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_coronary_syndrome" title="Acute coronary syndrome">Acute coronary</a> (<a href="/wiki/Unstable_angina" title="Unstable angina">Unstable angina</a>, <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">Myocardial infarction / heart attack</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Myocardial_infarction#Complications" title="Myocardial infarction">Sequelae</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>hours</i> (<a href="/wiki/Myocardial_stunning" title="Myocardial stunning">Myocardial stunning</a>, <a href="/wiki/Hibernating_myocardium" title="Hibernating myocardium">Hibernating myocardium</a>)<span style="font-weight:bold;">&#160;·</span> <i>days</i> (<a href="/wiki/Myocardial_rupture" title="Myocardial rupture">Myocardial rupture</a>)<span style="font-weight:bold;">&#160;·</span> <i>weeks</i> (<a href="/wiki/Aneurysm_of_heart" title="Aneurysm of heart">Aneurysm of heart</a>, <a href="/wiki/Dressler%27s_syndrome" title="Dressler's syndrome">Dressler's syndrome</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Layers</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pericardium" title="Pericardium">Pericardium</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pericarditis" title="Pericarditis">Pericarditis</a> (<a href="/wiki/Acute_pericarditis" title="Acute pericarditis">Acute</a>, <a href="/wiki/Pericarditis#Acute_vs._chronic" title="Pericarditis">Chronic</a>/<a href="/wiki/Constrictive_pericarditis" title="Constrictive pericarditis">Constrictive</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pericardial_effusion" title="Pericardial effusion">Pericardial effusion</a> (<a href="/wiki/Hemopericardium" title="Hemopericardium">Hemopericardium</a>, <a href="/wiki/Cardiac_tamponade" title="Cardiac tamponade">Cardiac tamponade</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Myocardium" title="Myocardium" class="mw-redirect">Myocardium</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Myocarditis" title="Myocarditis">Myocarditis</a> (<a href="/wiki/Chagas_disease" title="Chagas disease">Chagas disease</a>)
<p><a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">Cardiomyopathy</a>: <a href="/wiki/Dilated_cardiomyopathy" title="Dilated cardiomyopathy">Dilated</a> (<a href="/wiki/Alcoholic_cardiomyopathy" title="Alcoholic cardiomyopathy">Alcoholic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypertrophic_cardiomyopathy" title="Hypertrophic cardiomyopathy">Hypertrophic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Restrictive_cardiomyopathy" title="Restrictive cardiomyopathy">Restrictive</a> (<a href="/wiki/Loeffler_endocarditis" title="Loeffler endocarditis">Loeffler endocarditis</a>, <a href="/wiki/Cardiac_amyloidosis" title="Cardiac amyloidosis">Cardiac amyloidosis</a>, <a href="/wiki/Endocardial_fibroelastosis" title="Endocardial fibroelastosis">Endocardial fibroelastosis</a>)</p>
<a href="/wiki/Arrhythmogenic_right_ventricular_dysplasia" title="Arrhythmogenic right ventricular dysplasia">Arrhythmogenic right ventricular dysplasia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Endocardium" title="Endocardium">Endocardium</a>/<br />
<a href="/wiki/Valvular_heart_disease" title="Valvular heart disease">valves</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Endocarditis" title="Endocarditis">Endocarditis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Infective_endocarditis" title="Infective endocarditis">Infective endocarditis</a> (<a href="/wiki/Subacute_bacterial_endocarditis" title="Subacute bacterial endocarditis">Subacute bacterial endocarditis</a>)<span style="font-weight:bold;">&#160;·</span> <i>noninfective endocarditis</i> (<a href="/wiki/Nonbacterial_thrombotic_endocarditis" title="Nonbacterial thrombotic endocarditis">Nonbacterial thrombotic endocarditis</a>, <a href="/wiki/Libman-Sacks_endocarditis" title="Libman-Sacks endocarditis">Libman-Sacks endocarditis</a>)<br /></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Valves</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Mitral_valve" title="Mitral valve">mitral</a></i> (<a href="/wiki/Mitral_regurgitation" title="Mitral regurgitation">regurgitation</a>, <a href="/wiki/Mitral_valve_prolapse" title="Mitral valve prolapse">prolapse</a>, <a href="/wiki/Mitral_stenosis" title="Mitral stenosis">stenosis</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Aortic_valve" title="Aortic valve">aortic</a></i> (<a href="/wiki/Aortic_valve_stenosis" title="Aortic valve stenosis">stenosis</a>, <a href="/wiki/Aortic_insufficiency" title="Aortic insufficiency">insufficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Tricuspid_valve" title="Tricuspid valve">tricuspid</a></i> (<a href="/wiki/Tricuspid_valve_stenosis" title="Tricuspid valve stenosis">stenosis</a>, <a href="/wiki/Tricuspid_insufficiency" title="Tricuspid insufficiency">insufficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Pulmonary_valve" title="Pulmonary valve">pulmonary</a></i> (<a href="/wiki/Pulmonary_valve_stenosis" title="Pulmonary valve stenosis">stenosis</a>, <a href="/wiki/Pulmonary_valve_insufficiency" title="Pulmonary valve insufficiency">insufficiency</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Electrical_conduction_system_of_the_heart" title="Electrical conduction system of the heart">Conduction</a>/<br />
<a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">arrhythmia</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Bradycardia" title="Bradycardia">Bradycardia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Sinus_bradycardia" title="Sinus bradycardia">Sinus bradycardia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sick_sinus_syndrome" title="Sick sinus syndrome">Sick sinus syndrome</a><br />
<a href="/wiki/Heart_block" title="Heart block">Heart block</a>: <a href="/wiki/Sinoatrial_block" title="Sinoatrial block">Sinoatrial</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Atrioventricular_block" title="Atrioventricular block">AV</a> (<a href="/wiki/First_degree_AV_block" title="First degree AV block" class="mw-redirect">1°</a>, <a href="/wiki/Second_degree_AV_block" title="Second degree AV block" class="mw-redirect">2°</a>, <a href="/wiki/Third_degree_AV_block" title="Third degree AV block" class="mw-redirect">3°</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Intraventricular_block" title="Intraventricular block">Intraventricular</a> (<a href="/wiki/Bundle_branch_block" title="Bundle branch block">Bundle branch</a>/<a href="/wiki/Right_bundle_branch_block" title="Right bundle branch block">Right</a>/<a href="/wiki/Left_bundle_branch_block" title="Left bundle branch block">Left</a>, <a href="/wiki/Left_anterior_fascicular_block" title="Left anterior fascicular block">Left anterior fascicular</a>/<a href="/wiki/Left_posterior_fascicular_block" title="Left posterior fascicular block">Left posterior fascicular</a>, <a href="/wiki/Bifascicular_block" title="Bifascicular block">Bifascicular</a>/<a href="/wiki/Trifascicular_block" title="Trifascicular block">Trifascicular</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adams-Stokes_syndrome" title="Adams-Stokes syndrome">Adams-Stokes syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Tachycardia" title="Tachycardia">Tachycardia</a><br />
(<a href="/wiki/Paroxysmal_tachycardia" title="Paroxysmal tachycardia">paroxysmal</a> and <a href="/wiki/Sinus_tachycardia" title="Sinus tachycardia">sinus</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Supraventricular_tachycardia" title="Supraventricular tachycardia">Supraventricular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atrial_tachycardia" title="Atrial tachycardia">Atrial</a> (<a href="/wiki/Multifocal_atrial_tachycardia" title="Multifocal atrial tachycardia">Multifocal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Junctional_tachycardia" title="Junctional tachycardia">Junctional</a> (<a href="/wiki/AV_nodal_reentrant_tachycardia" title="AV nodal reentrant tachycardia">AV nodal reentrant</a>, <a href="/wiki/Junctional_ectopic_tachycardia" title="Junctional ectopic tachycardia">Junctional ectopic</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ventricular_tachycardia" title="Ventricular tachycardia">Ventricular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Torsades_de_pointes" title="Torsades de pointes">Torsades de pointes</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Catecholaminergic_polymorphic_ventricular_tachycardia" title="Catecholaminergic polymorphic ventricular tachycardia">Catecholaminergic polymorphic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Accelerated_idioventricular_rhythm" title="Accelerated idioventricular rhythm">Accelerated idioventricular rhythm</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Premature contraction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Premature_atrial_contraction" title="Premature atrial contraction">Atrial</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Premature_ventricular_contraction" title="Premature ventricular contraction">Ventricular</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pre-excitation_syndrome" title="Pre-excitation syndrome">Pre-excitation syndrome</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Wolff-Parkinson-White_syndrome" title="Wolff-Parkinson-White syndrome">Wolff-Parkinson-White</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Lown-Ganong-Levine_syndrome" title="Lown-Ganong-Levine syndrome">Lown-Ganong-Levine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Flutter/<a href="/wiki/Fibrillation" title="Fibrillation">fibrillation</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Atrial_flutter" title="Atrial flutter">Atrial flutter</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_flutter" title="Ventricular flutter">Ventricular flutter</a><span style="font-weight:bold;">&#160;·</span> <strong class="selflink">Atrial fibrillation</strong> (<a href="/wiki/Familial_atrial_fibrillation" title="Familial atrial fibrillation">Familial</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_fibrillation" title="Ventricular fibrillation">Ventricular fibrillation</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pacemaker" title="Pacemaker" class="mw-redirect">Pacemaker</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Wandering_pacemaker" title="Wandering pacemaker">Wandering pacemaker</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ectopic_pacemaker" title="Ectopic pacemaker">Ectopic pacemaker</a>/<a href="/wiki/Ectopic_beat" title="Ectopic beat">Ectopic beat</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Parasystole" title="Parasystole">Parasystole</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multifocal_atrial_tachycardia" title="Multifocal atrial tachycardia">Multifocal atrial tachycardia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pacemaker_syndrome" title="Pacemaker syndrome">Pacemaker syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Romano-Ward_syndrome" title="Romano-Ward syndrome">Romano-Ward syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Andersen-Tawil_syndrome" title="Andersen-Tawil syndrome">Andersen-Tawil syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Jervell_and_Lange-Nielsen_syndrome" title="Jervell and Lange-Nielsen syndrome">Jervell and Lange-Nielsen syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Cardiac_arrest" title="Cardiac arrest">Cardiac arrest</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sudden_cardiac_death" title="Sudden cardiac death">Sudden cardiac death</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Asystole" title="Asystole">Asystole</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pulseless_electrical_activity" title="Pulseless electrical activity">Pulseless electrical activity</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Other/ungrouped</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Right_axis_deviation" title="Right axis deviation">Right axis deviation</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Short_QT_syndrome" title="Short QT syndrome">Short QT syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sinoatrial_arrest" title="Sinoatrial arrest">Sinoatrial arrest</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/T_wave_alternans" title="T wave alternans">T wave alternans</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cardiac_fibrosis" title="Cardiac fibrosis">Cardiac fibrosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cardiomegaly" title="Cardiomegaly">Cardiomegaly</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ventricular_hypertrophy" title="Ventricular hypertrophy">Ventricular hypertrophy</a> (<a href="/wiki/Left_ventricular_hypertrophy" title="Left ventricular hypertrophy">Left</a>, <a href="/wiki/Right_ventricular_hypertrophy" title="Right ventricular hypertrophy">Right</a>/<a href="/wiki/Cor_pulmonale" title="Cor pulmonale">Cor pulmonale</a>)<br />
<a href="/wiki/Heart_failure" title="Heart failure">Heart failure</a> (<a href="/wiki/Cardiac_asthma" title="Cardiac asthma">Cardiac asthma</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>See also <a href="/wiki/Template:Congenital_malformations_and_deformations_of_circulatory_system" title="Template:Congenital malformations and deformations of circulatory system" class="mw-redirect">congenital</a>, <a href="/wiki/Template:Heart_and_thymus_neoplasia" title="Template:Heart and thymus neoplasia">neoplasia</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 28190/1000000
Post-expand include size: 347319/2048000 bytes
Template argument size: 155226/2048000 bytes
Expensive parser function count: 4/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:20869694-0!1!0!default!!en!2 and timestamp 20090403215436 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Atrial_fibrillation">http://en.wikipedia.org/wiki/Atrial_fibrillation</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Cardiac_electrophysiology" title="Category:Cardiac electrophysiology">Cardiac electrophysiology</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_September_2007" title="Category:Articles with unsourced statements since September 2007">Articles with unsourced statements since September 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2007" title="Category:Articles with unsourced statements since August 2007">Articles with unsourced statements since August 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Atrial_fibrillation" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Atrial_fibrillation" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Atrial_fibrillation&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Atrial_fibrillation&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atrial_fibrillation" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Atrial_fibrillation" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Atrial_fibrillation" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Atrial_fibrillation&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Atrial_fibrillation&amp;oldid=281364864" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Atrial_fibrillation&amp;id=281364864">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D8%B1%D8%AC%D9%81%D8%A7%D9%86_%D8%A3%D8%B0%D9%8A%D9%86%D9%8A">العربية</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Vorhofflimmern">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Fibrilaci%C3%B3n_auricular">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Fibrillation_auriculaire">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Fibrillazione_atriale">Italiano</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Boezemfibrilleren">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E5%BF%83%E6%88%BF%E7%B4%B0%E5%8B%95">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Atrieflimmer">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Migotanie_przedsionk%C3%B3w">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Fibrila%C3%A7%C3%A3o_auricular">Português</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Eteisv%C3%A4rin%C3%A4">Suomi</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 2 April 2009, at 20:53.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv72 in 0.068 secs. --></body></html>
